Document:

EX-10.1

 Exhibit 10.1 
  

 
  

AMENDED AND RESTATED 

SHAREHOLDERS’ AGREEMENT 

BY AND AMONG 

TPG PARTNERS V, L.P. 

TPG FOF V-A, L.P. 
 TPG
FOF V-B, L.P. 
 TPG PARTNERS VI, L.P. 

TPG FOF VI SPV, L.P. 

TPG BIOTECHNOLOGY PARTNERS III, L.P. 

TPG ICEBERG CO-INVEST LLC 

CPP INVESTMENT BOARD PRIVATE HOLDINGS INC. 

GREEN EQUITY INVESTORS V, L.P. 

GREEN EQUITY INVESTORS SIDE V, L.P. 

LGP ICEBERG CO-INVEST, LLC 

AND 
 IMS
HEALTH HOLDINGS, INC. 
 DATED AS OF [—], 2014 
  
  

 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	 ARTICLE I

DEFINITIONS
	   
   

			
	 Section 1.1
	 	 Definitions
	  	 	1	  
			
	 Section 1.2
	 	 Other Interpretive Provisions
	  	 	6	  
	
	ARTICLE II	  
	REPRESENTATIONS AND WARRANTIES	  
			
	 Section 2.1
	 	 Existence; Authority; Enforceability
	  	 	7	  
			
	 Section 2.2
	 	 Absence of Conflicts
	  	 	7	  
			
	 Section 2.3
	 	 Consents
	  	 	7	  
	
	ARTICLE III	  
	GOVERNANCE	  
			
	 Section 3.1
	 	 Board of Directors
	  	 	7	  
			
	 Section 3.2
	 	 Voting Agreement
	  	 	12	  
			
	 Section 3.3
	 	 Sharing of Information
	  	 	12	  
			
	 Section 3.3
	 	 Board Composition Following Controlled Company Status
	  	 	12	  
	
	 ARTICLE IV

REGISTRATION RIGHTS
	   
   

			
	 Section 4.1
	 	 Demand Registration
	  	 	13	  
			
	 Section 4.2
	 	 Shelf Registration
	  	 	15	  
			
	 Section 4.3
	 	 Piggyback Registration
	  	 	18	  
			
	 Section 4.4
	 	 Black-out Periods
	  	 	19	  
			
	 Section 4.5
	 	 Registration Procedures
	  	 	20	  
			
	 Section 4.6
	 	 Underwritten Offerings
	  	 	27	  
			
	 Section 4.7
	 	 No Inconsistent Agreements; Additional Rights
	  	 	28	  
			
	 Section 4.8
	 	 Registration Expenses
	  	 	28	  
			
	 Section 4.9
	 	 Indemnification
	  	 	29	  
			
	 Section 4.10
	 	 Rules 144 and 144A and Regulation S
	  	 	32	  
			
	 Section 4.11
	 	 Termination
	  	 	32	  
			
	 Section 4.12
	 	 Existing Registration Statements
	  	 	32	  

  
 i 

							
	ARTICLE V	  
	GENERAL PROVISIONS	  
			
	 Section 5.1
	 	 Assignment; Benefit
	  	 	33	  
			
	 Section 5.2
	 	 Freedom to Pursue Opportunities
	  	 	33	  
			
	 Section 5.3
	 	 Preemptive Rights
	  	 	34	  
			
	 Section 5.4
	 	 Termination
	  	 	34	  
			
	 Section 5.5
	 	 Severability
	  	 	34	  
			
	 Section 5.6
	 	 Entire Agreement; Amendment
	  	 	34	  
			
	 Section 5.7
	 	 Counterparts
	  	 	35	  
			
	 Section 5.8
	 	 Notices
	  	 	36	  
			
	 Section 5.9
	 	 Governing Law
	  	 	38	  
			
	 Section 5.10
	 	 Jurisdiction
	  	 	38	  
			
	 Section 5.11
	 	 Waiver of Jury Trial
	  	 	38	  
			
	 Section 5.12
	 	 Specific Performance
	  	 	38	  
			
	 Section 5.13
	 	 Subsequent Acquisition of Shares
	  	 	39	  

 Exhibit 1- Form of Indemnification Agreement 

  
 ii 

 THIS AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT (as it may be amended from time to time in
accordance with the terms hereof, the “Agreement”), dated as of [—], 2014, is made by and among TPG, CPPIB and LGP (each as defined herein) (collectively, the
“Sponsors”) and IMS Health Holdings, Inc. (the “Company”). 
 RECITALS 

WHEREAS, on February 26, 2010, the Sponsors, the Company and certain subsidiaries of the Company entered into a Shareholders’
Agreement (the “Prior Agreement”); 
 WHEREAS, on the date hereof, the Company is consummating an initial public offering
(the “IPO”) of its shares of common stock pursuant to an underwriting agreement dated [—], 2014; and 

WHEREAS, on the date hereof, the parties hereto desire to amend and restate the Prior Agreement in order to set forth their agreement with
respect to governance, registration rights and certain other matters. 
 NOW, THEREFORE, in consideration of the foregoing and the mutual
promises, covenants and agreements of the parties hereto, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 

ARTICLE I 
 DEFINITIONS

 Section 1.1 Definitions. As used in this Agreement, the following terms shall have the following meanings: 

“1-Year Unaffiliated Director” has the meaning set forth in Section 3.1(a). 

“90-Day Unaffiliated Director” has the meaning set forth in Section 3.1(a). 

“Adverse Disclosure” means public disclosure of material non-public information which, in the Board of Directors’ good
faith judgment, after consultation with independent outside counsel to the Company, (i) would be required to be made in any Registration Statement filed with the SEC by the Company so that such Registration Statement would not be materially
misleading; (ii) would not be required to be made at such time but for the filing of such Registration Statement; and (iii) the Company has a bona fide business purpose for not disclosing publicly. 

“Affiliate” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is
under common control with, such Person. For these purposes, “control” shall mean the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership
of voting securities, by contract or otherwise; provided that no Shareholder shall be deemed an Affiliate of the Company or any of its subsidiaries for purposes of this Agreement. 

 “Affiliated Officer” means an officer of the Company affiliated with any of TPG,
CPPIB or LGP. 
 “Agreement” has the meaning set forth in the preamble. 

“Articles” means the certificate of incorporation and by-laws of the Company. 

“Board of Directors” means the board of directors of the Company. 

“Business Day” means any day other than a Saturday, Sunday or day on which banking institutions in New York, New York are
authorized or obligated by law or executive order to close. 
 “Chief Executive Officer” means the chief executive officer
of the Company then in office. 
 “Company” has the meaning set forth in the preamble. 

“Company Shares” means the shares of common stock or other equity securities of the Company, and any securities into which
such shares of common stock or other equity securities shall have been changed or any securities resulting from any reclassification or recapitalization of such shares of common stock or other equity securities. 

“Confidential Information” has the meaning set forth in Section 3.3. 

“Coordination Agreement” has the meaning set forth in Section 5.1(a). 

“CPPIB” means CPP Investment Board Private Holdings Inc. and each of its Affiliates that is or becomes a Shareholder
hereunder. 
 “CPPIB Director” has the meaning set forth in Section 3.1(a). 

“CPPIB Supplemental Director” has the meaning set forth in Section 3.1(c)(ii). 

“Demand Notice” has the meaning set forth in Section 4.1(e). 

“Demand Period” has the meaning set forth in Section 4.1(d). 

“Demand Registration” has the meaning set forth in Section 4.1(a)(i). 

“Demand Registration Statement” has the meaning set forth in Section 4.1(a)(ii). 

“Demand Suspension” has the meaning set forth in Section 4.1(f). 

“Demanding Holder” means any Sponsor Demand Holder that exercises a right to demand Registration pursuant to Article IV.

 “Effectiveness Date” means the date on which Holders are no longer subject to any lock-up in connection with the
Company’s IPO. 

  
 2 

 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and any
successor thereto, and any rules and regulations promulgated thereunder, all as the same shall be in effect from time to time. 

“FINRA” means the Financial Industry Regulatory Authority. 

“Fund Indemnitor” has the meaning set forth in Section 3.1(l). 

“GEI V” means Green Equity Investors V, L.P. 

“Holder” means any holder of Registrable Securities who is a party hereto or who succeeds to rights hereunder pursuant to
Section 5.1. 
 “Indemnification Agreement” means an Indemnification Agreement in the form of Exhibit 1 hereto. 

“Indemnitee” has the meaning set forth in Section 3.1(l). 

“Initial Share Ownership” means, with respect to each Sponsor, the number of Company Shares held by such Sponsor immediately
following the closing of the IPO (including any additional closing pursuant to the underwriters’ over-allotment option). 

“IPO” has the meaning set forth in the recitals. 

“Issuer Free Writing Prospectus” means an issuer free writing prospectus, as defined in Rule 433 under the Securities Act,
relating to an offer of the Registrable Securities. 
 “Issuer Public Sale” has the meaning set forth in
Section 4.3(a). 
 “LGP” means, collectively, Green Equity Investors V, L.P., Green Equity Investors Side V, L.P. and
LGP Iceberg Coinvest, LLC and each of their respective Affiliates that is or becomes a Shareholder hereunder. 
 “LGP
Director” has the meaning set forth in Section 3.1(a). 
 “Loss” has the meaning set forth in
Section 4.9(a). 
 “Management Registration Rights Agreement” means the Registration and Preemptive Rights Agreement
dated as of February 26, 2010, by and among the Company and certain Managers, as the same may be amended from time to time. 

“Material Adverse Change” means (i) any general suspension of trading in, or limitation on prices for, securities on any
national securities exchange or in the over-the-counter market in the United States; (ii) the suspension of trading of any class of Registrable Securities by the SEC or any applicable national securities exchange on which such Registrable
Securities are listed; (iii) the declaration of a banking moratorium or any suspension of payments in respect of banks in the United States; (iv) a material outbreak or escalation of armed hostilities or other international or national
calamity involving the United States or the declaration by the United 

  
 3 

 
States of a national emergency or war or a material change in national or international financial, political or economic conditions; and (v) any event, change, circumstance or effect that is
or is reasonably likely to be materially adverse to the business, properties, assets, liabilities, condition (financial or otherwise), operations, results of operations or prospects of the Company and its subsidiaries taken as a whole. 

“Necessary Action” means, with respect to any party and a specified result, all actions (to the extent such actions are
permitted by law and within such party’s control) necessary to cause such result, including (i) voting or providing a written consent or proxy with respect to the Company Shares, (ii) causing the adoption of stockholders’
resolutions and amendments to the organizational documents of the Company, (iii) executing agreements and instruments, and (iv) making, or causing to be made, with governmental, administrative or regulatory authorities, all filings,
registrations or similar actions that are required to achieve such result. 
 “Person” means any individual, partnership,
limited liability company, corporation, trust, association, estate, unincorporated organization or a government or any agency or political subdivision thereof. 

“Piggyback Notice” has the meaning set forth in Section 4.3(a) 

“Piggyback Registration” has the meaning set forth in Section 4.3(a). 

“Potential Takedown Participant” has the meaning set forth in Section 4.2(f)(ii). 

“Prior Agreement” has the meaning set forth in the preamble. 

“Prospectus” means the prospectus included in any Registration Statement, all amendments and supplements to such prospectus,
including post-effective amendments, and all other material incorporated by reference in such prospectus. 
 “Qualifying
Shareholder” means each of TPG and CPPIB, so long as such Sponsor holds at least twenty-five percent (25%) of the Company Shares held by the Sponsors. 

“Registrable Securities” means any Company Shares held by any Holder and any securities held by any Holder that may be issued
or distributed or be issuable in respect of Company Shares by way of conversion, dividend, stock split or other distribution, merger, consolidation, exchange, recapitalization or reclassification or similar transaction; provided,
however, that any such Registrable Securities shall cease to be Registrable Securities to the extent (i) a Registration Statement with respect to the sale of such Registrable Securities has become effective under the Securities Act and
such Registrable Securities have been disposed of in accordance with the plan of distribution set forth in such Registration Statement, (ii) such Registrable Securities have been sold to the public pursuant to Rule 144 (or any similar
provisions then in force) under the Securities Act or (iii) such Registrable Securities shall have been otherwise Transferred and new certificates for them not bearing a legend restricting Transfer under the Securities Act shall have been
delivered by the Company and such securities may be publicly resold without Registration under the Securities Act without volume limitations or any other restrictions. 

  
 4 

 “Registration” means a registration with the SEC of any Company Shares for offer
and sale to the public under a Registration Statement. The terms “Register” and “Registering” shall have correlative meanings. 

“Registration Expenses” has the meaning set forth in Section 4.8. 

“Registration Statement” means any registration statement of the Company filed with, or to be filed with, the SEC under the
rules and regulations promulgated under the Securities Act, including the related Prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits and all material incorporated by
reference in such registration statement other than a registration statement (and related Prospectus) filed on Form S-8 or any successor form thereto. 

“Representatives” means, with respect to any Person, any of such Person’s officers, directors, employees, agents,
attorneys, accountants, actuaries, consultants, equity financing partners or financial advisors or other Person associated with, or acting on behalf of, such Person. 

“SEC” means the Securities and Exchange Commission or any successor agency having jurisdiction under the Securities Act. 

“Securities Act” means the Securities Act of 1933, as amended, and any successor thereto, and any rules and regulations
promulgated thereunder, all as the same shall be in effect from time to time. 
 “Shareholder” means any holder of Company
Shares that is or becomes a party to this Agreement from time to time in accordance with the provisions hereof. 
 “Shelf
Notice” has the meaning set forth in Section 4.2(c). 
 “Shelf Period” has the meaning set forth in
Section 4.2(b). 
 “Shelf Registration” means a Registration effected pursuant to Section 4.2. 

“Shelf Registration Statement” means a Registration Statement of the Company filed with the SEC on either (i) Form S-3
(or any successor form or other appropriate form under the Securities Act) or (ii) if the Company is not permitted to file a Registration Statement on Form S-3, an evergreen Registration Statement on Form S-1 (or any successor form or other
appropriate form under the Securities Act), in each case for an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act (or any similar rule that may be adopted by the SEC) covering the Registrable Securities, as
applicable. 
 “Shelf Suspension” has the meaning set forth in Section 4.2(d). 

“Shelf Takedown Request” has the meaning set forth in Section 4.2(f). 

“Sponsor” has the meaning set forth in the preamble. 

  
 5 

 “Sponsor Demand Holder” has the meaning set forth in Section 4.1(a)(i).

 “Sponsor Director” means any director designated for nomination by TPG, CPPIB or LGP. 

“TPG” means, collectively, TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG FOF VI SPV,
L.P., TPG Biotechnology Partners III, L.P. and TPG Iceberg Co-Invest LLC, and each of their respective Affiliates that is or becomes a Shareholder hereunder. 

“TPG Director” has the meaning set forth in Section 3.1(a). 

“TPG Supplemental Director” has the meaning set forth in Section 3.1(b)(ii). 

“Transfer” means, with respect to any Company Shares, a direct or indirect transfer, sale, exchange, assignment, pledge,
hypothecation or other encumbrance or other disposition of such Company Shares, including the grant of an option or other right, whether directly or indirectly, whether voluntarily, involuntarily or by operation of law; and
“Transferred”, “Transferee” and “Transferability” shall each have a correlative meaning. 

“Unaffiliated Director” means a director that meets the independence criteria set forth in Rule 10A-3 under the Exchange Act.

 “Underwritten Offering” means a Registration in which securities of the Company are sold to an underwriter or
underwriters on a firm commitment basis for reoffering to the public, including any block sale to a financial institution conducted as an underwritten public offering. 

“Underwritten Shelf Takedown” has the meaning set forth in Section 4.2(e). 

“WKSI” means any Securities Act registrant that is a well-known seasoned issuer as defined in Rule 405 under the Securities
Act at the most recent eligibility determination date specified in paragraph (2) of that definition. 
 Section 1.2 Other
Interpretive Provisions. (a) The meanings of defined terms are equally applicable to the singular and plural forms of the defined terms. 

(b) The words “hereof”, “herein”, “hereunder” and similar words refer to this Agreement as
a whole and not to any particular provision of this Agreement; and any subsection and section references are to this Agreement unless otherwise specified. 

(c) The term “including” is not limiting and means “including without limitation.” 

(d) The captions and headings of this Agreement are for convenience of reference only and shall not affect the interpretation of this
Agreement. 
 (e) Whenever the context requires, any pronouns used herein shall include the corresponding masculine, feminine or neuter
forms. 

  
 6 

 ARTICLE II 

REPRESENTATIONS AND WARRANTIES 

Each of the parties to this Agreement hereby represents and warrants to each other party to this Agreement that as of the date such party
executes this Agreement: 
 Section 2.1 Existence; Authority; Enforceability. Such party has the power and authority to enter
into this Agreement and to carry out its obligations hereunder. Such party is duly organized and validly existing under the laws of its jurisdiction of organization, and the execution of this Agreement, and the consummation of the transactions
contemplated herein, have been authorized by all necessary action, and no other act or proceeding on its part is necessary to authorize the execution of this Agreement or the consummation of any of the transactions contemplated hereby. This
Agreement has been duly executed by it and constitutes its legal, valid and binding obligations, enforceable against it in accordance with its terms. 

Section 2.2 Absence of Conflicts. The execution and delivery by such party of this Agreement and the performance of its
obligations hereunder does not and will not (a) conflict with, or result in the breach of any provision of the constitutive documents of such party; (b) result in any violation, breach, conflict, default or event of default (or an event
which with notice, lapse of time, or both, would constitute a default or event of default), or give rise to any right of acceleration or termination or any additional payment obligation, under the terms of any contract, agreement or permit to which
such party is a party or by which such party’s assets or operations are bound or affected; or (c) violate any law applicable to such party. 

Section 2.3 Consents. Other than any consents which have already been obtained, no consent, waiver, approval, authorization,
exemption, registration, license or declaration is required to be made or obtained by such party in connection with (a) the execution, delivery or performance of this Agreement or (b) the consummation of any of the transactions
contemplated herein. 
 ARTICLE III 

GOVERNANCE 

Section 3.1 Board of Directors. 

(a) Composition of Initial Board. The Shareholders and the Company shall take all Necessary Action to cause the Board of Directors to
be comprised initially of seven (7) directors, (A) two (2) of whom shall be designated by TPG (each, a “TPG Director”), (B) one (1) of whom shall be designated by CPPIB (the “CPPIB
Director”), (C) one (1) of whom shall be designated by GEI V (the “LGP Director”), (D) one (1) of whom shall be the Chief Executive Officer, (E) one (1) of whom shall be an Unaffiliated
Director (the “Initial Unaffiliated Director”) and (F) one (1) additional director jointly designated by TPG and CPPIB (the “Joint Director”). Within ninety (90) days following the date of this
Agreement, the Company and the 

  
 7 

 
Sponsors shall take all Necessary Action to cause the Board of Directors to increase in size by one (1) to eight (8) directors and to fill such vacancy with one (1) Unaffiliated
Director (the “90-Day Unaffiliated Director”). Within one year following the date of this Agreement, the Company and the Sponsors shall take all Necessary Action to cause the Board of Directors to increase in size by one (1) to
nine (9) directors and to fill such vacancy with one (1) Unaffiliated Director (the “1-Year Unaffiliated Director”). The foregoing directors shall be divided into three classes of directors, each of which directors shall
serve for staggered three year-terms as follows: 
 (1) the class I directors shall include: one (1) TPG Director, the CPPIB Director
and the Chief Executive Officer; 
 (2) the class II directors shall include: one (1) TPG Director, the LGP Director and the 90-Day
Unaffiliated Director; and 
 (3) the class III directors shall include: the Initial Unaffiliated Director, the Joint Director and the
1-Year Unaffiliated Director. 
 The initial term of the class I directors shall expire immediately following the Company’s 2015 annual
meeting of stockholders at which directors are elected. The initial term of the class II directors shall expire immediately following the Company’s 2016 annual meeting of stockholders at which directors are elected. The initial term of the
class III directors shall expire immediately following the Company’s 2017 annual meeting at which directors are elected. 
 (b) TPG
Representation. 
 (i) For so long as TPG holds a number of Company Shares representing at least the percentage of its
Initial Share Ownership shown below, the Company shall, and the Sponsors shall take all Necessary Action to, include in the slate of nominees recommended by the Board of Directors for election as directors at each applicable annual or special
meeting of shareholders at which directors are to be elected that number of individuals designated by TPG that, if elected, will result in TPG having the number of directors serving on the Board of Directors that is shown below. 

 

					
	 Percent of Initial Share Ownership
	  	Number of TPG Directors	 
	 50% or greater
	  	 	2	  
	 Less than 50% but greater than or equal to 5%
	  	 	1	  

 (ii) In addition, for so long as TPG holds a number of Company Shares representing at least the
percentage of its Initial Share Ownership shown below, upon receiving a written request from TPG, the Company will take all Necessary Action to cause the Board of Directors as soon as practicable to: (a) increase the size of the Board of
Directors to permit the inclusion of the number of additional directors shown below on the Board of Directors; and (b) appoint such directors to fill the vacancies created thereby as are specified by TPG. Subject to the Articles, any director
so appointed (each, a “TPG Supplemental Director”) shall be assigned to such class of directors to be elected at the annual meeting that is latest to occur of the then-existing classes of directors, unless otherwise agreed by
holders of at least sixty-five percent (65%) of the Shares held by the 

  
 8 

 
Sponsors. Thereafter, for so long as TPG holds a number of Company Shares representing at least the percentage of its Initial Share Ownership shown below, in addition to any directors designated
in accordance with Section 3.1(b)(i), the Company shall, and the Sponsors shall take all Necessary Action to, include in the slate of nominees recommended by the Board of Directors for election as directors at each applicable annual or special
meeting of shareholders at which directors are to be elected that number of individuals designated by TPG that, if elected, will result in TPG having the number of TPG Supplemental Directors serving on the Board of Directors that is shown below.

  

					
	 Percent of Initial Share Ownership
	  	Number of TPG Supplemental Directors	 
	 50% or greater
	  	 	2	  
	 Less than 50% but greater than or equal to 10%
	  	 	1	  

 (c) CPPIB Representation. 

(i) For so long as CPPIB holds a number of Company Shares representing at least ten percent (10%) of its Initial Share
Ownership, the Company shall, and the Sponsors shall take all Necessary Action to, include in the slate of nominees recommended by the Board of Directors for election as directors at each applicable annual or special meeting of shareholders at which
directors are to be elected that number of individuals designated by CPPIB that, if elected, will result in there being one (1) CPPIB Director serving on the Board of Directors. 

(ii) In addition, for so long as CPPIB holds a number of Company Shares representing at least twenty-five percent (25%) of
its Initial Share Ownership, upon receiving a written request from CPPIB, the Company will take all Necessary Action to cause the Board of Directors as soon as practicable to: (a) increase the size of the Board of Directors to permit the
inclusion of one (1) additional director on the Board of Directors; and (b) appoint such director to fill the vacancy created thereby as is specified by CPPIB. Subject to the Articles, any director so appointed (the “CPPIB
Supplemental Director”) shall be assigned to such class of directors to be elected at the annual meeting that is latest to occur of the then-existing classes of directors, unless otherwise agreed by holders of at least sixty-five percent
(65%) of the Shares held by the Sponsors. Thereafter, for so long as CPPIB holds a number of Company Shares representing at least twenty-five percent (25%) of its Initial Share Ownership, in addition to any directors designated in
accordance with Section 3.1(c)(i), the Company shall, and the Sponsors shall take all Necessary Action to, include in the slate of nominees recommended by the Board of Directors for election as directors at each applicable annual or special
meeting of shareholders at which directors are to be elected that number of individuals designated by CPPIB that, if elected, will result in CPPIB having one (1) CPPIB Supplemental Director serving on the Board of Directors. 

(d) LGP Representation. For so long as LGP holds a number of Company Shares representing at least fifty percent (50%) of its
Initial Share Ownership, the Company shall, and the Sponsors shall take all Necessary Action to, include in the slate of nominees 

  
 9 

 
recommended by the Board of Directors for election as directors at each applicable annual or special meeting of shareholders at which directors are to be elected that number of individuals
designated by LGP that, if elected, will result in there being one (1) LGP Director serving on the Board of Directors. 
 (e) Joint
Director Seat. For so long as TPG and CPPIB collectively hold a number of Company Shares representing at least fifty percent (50%) of their collective Initial Share Ownership, the Company shall, and the Sponsors shall take all Necessary
Action to, include in the slate of nominees recommended by the Board of Directors for election as directors at each applicable annual or special meeting of shareholders at which directors are to be elected that number of individuals designated by
TPG and CPPIB jointly that, if elected, will result in there being one (1) Joint Director serving on the Board of Directors. 
 (f)
Decrease in Sponsor Directors. Upon any decrease in the number of directors that a Sponsor is entitled to designate for nomination to the Board of Directors, such Sponsor shall take all Necessary Action to cause the appropriate number of
Sponsor Directors to offer to tender resignation. If such resignation is then accepted by the Board of Directors, the Company and the Sponsors shall take all Necessary Action to cause the authorized size of the Board of Directors to be reduced
accordingly. 
 (g) CEO Representation. If the term of the Chief Executive Officer as a director on the Board of Directors is to
expire in conjunction with any annual or special meeting of shareholders at which directors are to be elected, the Sponsors agree to take all Necessary Action to cause the Chief Executive Officer to be included in the slate of nominees recommended
by the Board of Directors for election. 
 (h) Vacancies. Except as provided in Section 3.1(f), and subject to the Articles,
(i) each Sponsor shall have the exclusive right to remove its designees from the Board, and the Company and the Sponsors shall take all Necessary Action to cause the removal of any such designee at the request of the designating Sponsor and
(ii) each Sponsor shall have the exclusive right to designate directors for election to the Board of Directors to fill vacancies created by reason of death, removal or resignation of its designees to the Board of Directors, and the Company and
the Sponsors shall take all Necessary Action to cause any such vacancies to be filled by replacement directors designated by such designating Sponsor as promptly as reasonably practicable; provided, that in the case of the Joint Director, TPG
and CPPIB must jointly agree to any such removal and to fill such vacancy. For the avoidance of doubt and notwithstanding anything to the contrary in this paragraph, no Sponsor shall have the right to designate a replacement director, and the
Company and the Sponsors shall not be required to take any action to cause any vacancy to be filled by any such designee, to the extent that election or appointment of such designee to the Board of Directors would result in a number of directors
designated by such Sponsor in excess of the number of directors that such Sponsor is then entitled to designate for membership on the Board of Directors pursuant to Section 3.1(b), (c) or (d), as applicable. 

(i) Additional Unaffiliated Directors. Subject to Sections 3.1(b)(ii) and 3.1(c)(ii), for so long as any Sponsor has the right to
designate at least one (1) director for nomination under this Agreement, the Company will take all Necessary Action to ensure that the 

  
 10 

 
number of directors serving on the Board of Directors shall not exceed nine (9); provided, that the number of directors may be increased if necessary to satisfy the requirements of
applicable laws and stock exchange regulations. 
 (j) Committees. Subject to applicable laws and stock exchange regulations, each of
TPG and CPPIB shall have the right to have a representative appointed to serve on each committee of the Board of Directors other than the audit committee for so long as such Sponsor has the right to designate at least one (1) director for
election to the Board of Directors and holds at least ten percent (10%) of the outstanding shares of the Company’s common stock. Prior to the Trigger Date (as defined in the Articles), a quorum of each such committee shall consist of a
majority of the members of the committee and the presence of at least one TPG Director (unless waived by such TPG Director) and one CPPIB Director (unless waived by such CPPIB Director); provided, however, that if a quorum is not
present at the originally scheduled meeting of any such committee due to the absence of a TPG Director or a CPPIB Director, then such meeting shall be adjourned and a notice to the members of such committee of the rescheduled meeting shall be given
in accordance with the Company’s bylaws, and if a quorum is not present at the rescheduled meeting due to the absence of a TPG Director (in the event there were no TPG Directors present at such adjourned meeting) or a CPPIB Director (in the
event there were no CPPIB Directors present at such adjourned meeting), a quorum shall consist of at least a majority of such committee, whether or not at least one TPG Director (in the event there were no TPG Directors present at such adjourned
meeting) or one CPPIB Director (in the event there were no CPPIB Directors present at such adjourned meeting) is present. 
 (k)
Reimbursement of Expenses. The Company shall reimburse the directors for all reasonable out-of-pocket expenses incurred in connection with their attendance at meetings of the Board of Directors and any committees thereof, including without
limitation travel, lodging and meal expenses. 
 (l) Indemnification Agreements; D&O Insurance; Indemnification Priority. On or
prior to the date of this Agreement the Company shall, and shall cause each IMS Company (as defined in the Indemnification Agreement) to, execute and deliver to each Sponsor Director serving as a director of the Company as of the date hereof an
Indemnification Agreement. From and after the date hereof, simultaneously with any person becoming a Sponsor Director the Company shall, and shall cause each IMS Company to, execute and deliver to each such Sponsor Director an Indemnification
Agreement dated the date such Sponsor Director becomes a director of the Company. The Company shall obtain customary director and officer indemnity insurance on commercially reasonable terms. The Company hereby acknowledges that any director,
officer or other indemnified person covered by any such indemnity insurance policy (any such Person, an “Indemnitee”) may have certain rights to indemnification, advancement of expenses and/or insurance provided by any of the
Sponsors and certain of their respective Affiliates (collectively, the “Fund Indemnitors”). The Company hereby agrees (i) that the Company and its subsidiaries shall be the indemnitors of first resort (i.e., their respective
obligations to an Indemnitee shall be primary and any obligation of any Fund Indemnitor to advance expenses or to provide indemnification for the same expenses or liabilities incurred by Indemnitee shall be secondary) and the obligation of the
Company and its subsidiaries to indemnify and advance expenses to an Indemnitee shall be joint and several, and (ii) the Company irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all

  
 11 

 
claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Fund
Indemnitors on behalf of an Indemnitee with respect to any claim for which such Indemnitee has sought indemnification from the Company or any of its subsidiaries, as the case may be, shall affect the foregoing and the Fund Indemnitors shall have a
right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such Indemnitee against the Company or any of its subsidiaries, as the case may be. 

Section 3.2 Voting Agreement. Each Sponsor agrees to cast all votes to which such Sponsor is entitled in respect of its Company
Shares, whether at any annual or special meeting, by written consent or otherwise, so as to cause to be elected to the Board of Directors those individuals designated in accordance with this Article III and to otherwise effect the intent of this
Article III. Prior to the first date on which the Sponsors cease collectively to beneficially own (directly or indirectly) more than fifty percent (50%) of the Company’s outstanding shares of common stock, each Sponsor agrees not to take
action to remove each other’s director nominees from office pursuant to Article V(c) of the Articles unless such removal is for cause. 

Section 3.3 Sharing of Information. To the extent permitted by antitrust, competition or any other applicable law, each
Shareholder agrees and acknowledges that the directors designated by TPG, CPPIB and LGP may share confidential, non-public information (“Confidential Information”) about the Company and its subsidiaries with TPG, CPPIB and LGP,
respectively. Each Shareholder recognizes that it, or its Affiliates and Representatives, has acquired or will acquire Confidential Information the use or disclosure of which could cause the Company substantial loss and damages that could not be
readily calculated and for which no remedy at law would be adequate. Accordingly, each Shareholder covenants and agrees with the Company that it will not (and will cause its respective Affiliates and Representatives not to) at any time, except with
the prior written consent of the Company, directly or indirectly, disclose any Confidential Information known to it, unless (i) such information becomes known to the public through no fault of such Shareholder, (ii) disclosure is required
by applicable law, provided that such Shareholder promptly notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure, (iii) such information was available or becomes available to
such Shareholder before, on or after the date hereof, without restriction, from a source (other than the Company) without any breach of duty to the Company or (iv) such information was independently developed by the Shareholder or its
representatives without the use of the Confidential Information. Notwithstanding anything herein to the contrary, nothing in this Agreement shall prohibit a Shareholder from disclosing Confidential Information to any Affiliate, Representative,
limited partner, member or shareholder of such Shareholder; provided, that such Shareholder shall be responsible for any breach of this Section 3.3 by any such person 

Section 3.4 Board Composition Following Controlled Company Status. The Company and the Sponsors shall take all Necessary Action to
ensure that the composition of the Board of Directors complies with all applicable law and stock exchange rules upon loss of the “controlled company” exemption under applicable stock exchange rules. 

  
 12 

 ARTICLE IV 

REGISTRATION RIGHTS 

Section 4.1 Demand Registration. 

(a) Demand by Holders. 

(i) If at any time after the Effectiveness Date, there is no currently effective Shelf Registration Statement on file with the
SEC, any of TPG, CPPIB and LGP, in each case so long as it holds Registrable Securities (each, a “Sponsor Demand Holder”), shall have the right to make a written request to the Company for Registration of all or part of the
Registrable Securities held by it on (x) Form S-1 or any successor form or any similar long-form registration statement (a “Long-Form Registration”), or (y) Form S-3 or any successor form or any similar short-form
registration statement (a “Short-Form Registration”) if the Company is qualified to use such short form. Any such request pursuant to clauses (i) and (ii) of this Section 4.1(a) shall hereinafter be referred to as a
“Demand Registration.” Each request for a Demand Registration shall specify (x) the kind and aggregate amount of Registrable Securities to be Registered and (y) the intended methods of disposition thereof. 

(ii) As promptly as practicable, the Company shall file a Registration Statement relating to such Demand Registration (a
“Demand Registration Statement”), and shall use its reasonable best efforts to cause (a) such Demand Registration Statement to promptly be declared effective under the Securities Act, and (b) the offer and sale of
Registrable Securities to be otherwise registered and/or qualified under the “Blue Sky” laws of such jurisdictions as any Holder of Registrable Securities being registered under such Registration Statement or any underwriter, if any,
reasonably requests. 
 (iii) Notwithstanding anything to the contrary herein, no Demand Registration Statement or Shelf
Registration Statement shall be required to be effective within one (1) year following the closing of the IPO unless approved by the Sponsors holding, in the aggregate, at least sixty-five percent (65%) of the Company Shares held by the
Sponsors. 
 (b) Limitation on Demand Registrations. Subject to Section 4.1(a), each Sponsor Demand Holder shall have the right
to request up to three (3) Long-Form Registrations and an unlimited number of Short-Form Registrations. The Company shall not be obligated to take any action to effect any Demand Registration if a Demand Registration was declared effective or
an Underwritten Shelf Takedown was consummated within the preceding ninety (90) days (unless otherwise consented to by the Company’s Board of Directors). 

(c) Demand Withdrawal. A Demanding Holder, and any other Holder that has requested its Registrable Securities be included in a Demand
Registration pursuant to Section 4.1(e), may withdraw all or any portion of its Registrable Securities included in a Demand Registration from such Demand Registration at any time prior to the effectiveness of the applicable Demand Registration
Statement. Upon receipt of a notice to such effect from a Demanding Holder (or if there is more than one Demanding Holder, from all such Demanding 

  
 13 

 
Holders) with respect to all of the Registrable Securities included by such Demanding Holder(s) in such Demand Registration, the Company shall cease all efforts to secure effectiveness of the
applicable Demand Registration Statement and such Registration nonetheless shall be deemed a Demand Registration for purposes of Section 4.1(b) unless (i) the withdrawing Demanding Holder(s) shall have paid or reimbursed the Company for
its or their pro rata share of all reasonable and documented out-of-pocket fees and expenses incurred by the Company in connection with the Registration (based on the number of securities the Demanding Holder(s) sought to register, as
compared to the total number of securities included in such Demand Registration Statement) or (ii) such withdrawal is made following the occurrence of a Material Adverse Change or because the Registration would require the Company to make an
Adverse Disclosure. 
 (d) Effective Registration. The Company shall be deemed to have effected a Demand Registration if the Demand
Registration Statement has become effective and remains effective for not less than one hundred eighty (180) days (or such shorter period as will terminate when all Registrable Securities covered by such Demand Registration Statement have been
sold or withdrawn), or if such Registration Statement relates to an Underwritten Offering, such longer period as in the opinion of counsel for the underwriter or underwriters a Prospectus is required by law to be delivered in connection with sales
of Registrable Securities by an underwriter or dealer (the applicable period, the “Demand Period”). No Demand Registration shall be deemed to have been effected if (i) during the Demand Period such Registration is interfered
with by any stop order, injunction or other order or requirement of the SEC or other governmental agency or court or (ii) the conditions to closing specified in the underwriting agreement, if any, entered into in connection with such
Registration are not satisfied other than by reason of a wrongful act, misrepresentation or breach of such applicable underwriting agreement by a participating Holder. 

(e) Demand Notice. Promptly upon receipt of any request for a Demand Registration (but in no event more than two (2) Business Days
thereafter), the Company shall deliver a written notice (a “Demand Notice”) of any such Registration request to all other Holders of Registrable Securities, and the Company shall include in such Demand Registration all such
Registrable Securities with respect to which the Company has received written requests for inclusion therein within three (3) Business Days after the date that the Demand Notice has been delivered. All requests made pursuant to this
Section 4.1(e) shall specify the aggregate amount of Registrable Securities to be registered and the intended method of distribution of such securities. 

(f) Delay in Filing; Suspension of Registration. If the filing, initial effectiveness or continued use of a Demand Registration
Statement at any time would require the Company to make an Adverse Disclosure, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, the Demand Registration
Statement (a “Demand Suspension”); provided, however, that the Company shall not be permitted to exercise a Demand Suspension (i) more than once during any twelve (12)-month period or (ii) for a period
exceeding thirty (30) days on any one occasion. In the case of a Demand Suspension, the Holders agree to suspend use of the applicable Prospectus and any Issuer Free Writing Prospectuses in connection with any sale or purchase, or offer to sell
or purchase, Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the Holders upon the termination of any Demand Suspension, amend or 

  
 14 

 
supplement the Prospectus or any Issuer Free Writing Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Holders such numbers of copies of the
Prospectus and any Issuer Free Writing Prospectus as so amended or supplemented as the holders may reasonably request. The Company shall, if necessary, supplement or make amendments to the Demand Registration Statement, if required by the
registration form used by the Company for the Demand Registration or by the instructions applicable to such registration form or by the Securities Act or the rules or regulations promulgated thereunder or as may reasonably be requested by the
Holders of a majority of Registrable Securities that are included in such Demand Registration Statement. 
 (g) Underwritten
Offering. If a Demanding Holder so requests, an offering of Registrable Securities pursuant to a Demand Registration shall be in the form of an Underwritten Offering. The participating Sponsor Demand Holders shall have the right to select the
managing underwriter or underwriters to administer the offering; provided that such managing underwriter or underwriters shall be reasonably acceptable to the Company and TPG. 

(h) Priority of Securities Registered Pursuant to Demand Registrations. If the managing underwriter or underwriters of a proposed
Underwritten Offering of the Registrable Securities included in a Demand Registration (or, in the case of a Demand Registration not being underwritten, the Demanding Holders holding a majority of the Demanding Holders’ Registrable Securities
included therein) advise the Board of Directors in writing that, in its or their opinion, the number of securities requested to be included in such Demand Registration exceeds the number which can be sold in such offering without being likely to
have a significant adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered, then the securities to be included in such Registration shall be (x) first, allocated pro
rata among the Holders that have requested to participate in such Demand Registration (based on the relative number of Registrable Securities requested to be included therein), (y) second, and only if all the securities referred to in
clause (x) have been included, the number of other securities that, in the opinion of such managing underwriter or underwriters (or Demanding Holders holding a majority of the Demanding Holders’ Registrable Securities to be included in
such Registration, if applicable) can be sold without having such adverse effect. 
 (i) In the event that a Holder requests to participate
in a Registration pursuant to this Section 4.1 in connection with a distribution of Registrable Securities to its partners or members, the Registration shall provide for resale by such partners or members, if requested by the Holder. 

Section 4.2 Shelf Registration. 

(a) Filing. As promptly as practicable following a demand by any Sponsor Demand Holder at any time after the Effectiveness Date, the
Company shall file with the SEC a Shelf Registration Statement relating to the offer and sale of Registrable Securities by any Holders thereof from time to time in accordance with the methods of distribution elected by such Holders and set forth in
the Shelf Registration Statement and, as promptly as practicable thereafter, shall use its reasonable best efforts to cause such Shelf Registration Statement to become effective under the Securities Act. If on the date of such demand (i) the
Company is a WKSI, then the Sponsor Demand Holders may request Registration of an unspecified amount of 

  
 15 

 
Registrable Securities and (ii) the Company is not a WKSI, then the Sponsor Demand Holders shall specify the aggregate amount of Registrable Securities to be registered. If, on the date of
any such demand, the Company does not qualify to file a Shelf Registration Statement, then the provisions of Section 4.1 shall apply instead. 

(b) Continued Effectiveness. The Company shall use its reasonable best efforts to keep such Shelf Registration Statement continuously
effective under the Securities Act in order to permit the Prospectus forming a part thereof to be usable by Holders until the earlier of (i) the date as of which all Registrable Securities have been sold pursuant to the Shelf Registration
Statement or another Registration Statement filed under the Securities Act (but in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder) and (ii) the date as of which each of
the Holders is permitted to sell its Registrable Securities without Registration pursuant to Rule 144 under the Securities Act without volume limitations or other restrictions on Transfer thereunder (such period of effectiveness, the “Shelf
Period”). Subject to Section 4.2(d), the Company shall not be deemed to have used its reasonable best efforts to keep the Shelf Registration Statement effective during the Shelf Period if the Company voluntarily takes any action or
omits to take any action that would result in Holders of the Registrable Securities covered thereby not being able to offer and sell any Registrable Securities pursuant to such Shelf Registration Statement during the Shelf Period, unless such action
or omission is required by applicable law. 
 (c) Shelf Notice. Promptly upon receipt of any request to file a Shelf Registration
Statement (but in no event more than two (2) Business Days thereafter), the Company shall deliver a written notice (a “Shelf Notice”) of any such request to all other Holders of Registrable Securities. If the Company is not
then a WKSI, the Company shall include in such Registration all such Registrable Securities with respect to which the Company has received written requests for inclusion therein within three (3) Business Days after the date that the Shelf
Notice has been delivered. If the Company is then a WKSI, the Company shall include in such Registration an unspecified amount of Registrable Securities. 

(d) Suspension of Registration. If the continued use of such Shelf Registration Statement at any time would require the Company to make
an Adverse Disclosure, the Company may, upon giving prompt prior written notice of such action to the Holders, suspend use of the Shelf Registration Statement (a “Shelf Suspension”); provided, however, that the Company
shall not be permitted to exercise a Shelf Suspension (i) more than one time during any twelve (12)-month period, or (ii) for a period exceeding thirty (30) days on any one occasion. In the case of a Shelf Suspension, the Holders
agree to suspend use of the applicable Prospectus and any Issuer Free Writing Prospectuses in connection with any sale or purchase of, or offer to sell or purchase, Registrable Securities, upon receipt of the notice referred to above. The Company
shall immediately notify the Holders upon the termination of any Shelf Suspension, amend or supplement the Prospectus or any Issuer Free Writing Prospectuses, if necessary, so it does not contain any untrue statement or omission and furnish to the
Holders such numbers of copies of the Prospectus as so amended or supplemented or any Issuer Free Writing Prospectus as the Holders may reasonably request. The Company shall, if necessary, supplement or make amendments to the Shelf Registration
Statement, if required by the registration form used by the Company for the Shelf Registration or by the instructions applicable to such registration form or by the Securities Act or the rules or regulations promulgated thereunder or as may
reasonably be requested by the Holders of a majority of the Registrable Securities then outstanding. 

  
 16 

 (e) Underwritten Offering. If any Sponsor Demand Holder, in consultation with each other
Sponsor, so elects, an offering of Registrable Securities under a Shelf Registration Statement shall be in the form of an Underwritten Offering (each such offering, an “Underwritten Shelf Takedown”), and the Company shall amend or
supplement the Shelf Registration Statement for such purpose. The participating Sponsor Demand Holders shall have the right to select the managing underwriter or underwriters to administer such offering; provided that such managing
underwriter or underwriters shall be reasonably acceptable to the Company and TPG. 
 (f) Shelf Takedowns. 

(i) At any time during which the Company has an effective Shelf Registration Statement with respect to a Sponsor Demand
Holders’ Registrable Securities, by notice to the Company specifying the intended method or methods of disposition thereof, such Sponsor Demand Holder may make a written request (a “Shelf Takedown Request”) to the Company to
effect an offering of such Registrable Securities, including an Underwritten Shelf Takedown, of all or a portion of such Holder’s Registrable Securities that are covered by such Shelf Registration Statement, and as soon as practicable the
Company shall amend or supplement the Shelf Registration Statement for such purpose. 
 (ii) Promptly upon receipt of a Shelf
Takedown Request (but in no event more than two (2) Business Days thereafter) for any Underwritten Shelf Takedown, the Company shall deliver a notice (a “Shelf Takedown Notice”) to each other Sponsor Demand Holder with
Registrable Securities covered by the applicable Registration Statement, or to all other Sponsor Demand Holders if such Registration Statement is undesignated (each a “Potential Takedown Participant”). The Shelf Takedown Notice
shall offer each such Potential Takedown Participant the opportunity to include in any Underwritten Shelf Takedown that number of Registrable Securities as each such Holder may request in writing. The Company shall include in the Underwritten Shelf
Takedown all such Registrable Securities with respect to which the Company has received written requests for inclusion therein within three (3) Business Days after the date that the Shelf Takedown Notice has been delivered. Each such
Holder’s request to participate in an Underwritten Shelf Takedown shall be binding on such Holder; provided, that each such Potential Takedown Participant that elects to participate may condition its participation on the Underwritten
Shelf Takedown being completed within ten (10) Business Days of its acceptance at a price per share (after giving effect to any underwriters’ discounts or commissions) to such Holder of not less than ninety percent (90%) of the
closing price for the shares on their principal trading market on the Business Day immediately prior to such Holder’s election to participate. 

(iii) The Company shall not be obligated to take any action to effect any Underwritten Shelf Takedown if a Demand Registration
or an Underwritten Shelf Takedown was consummated within the preceding forty-five (45) days (unless otherwise consented to by the Company’s Board of Directors). 

  
 17 

 (g) Priority of Securities Sold Pursuant to Shelf Registrations. If the managing
underwriter or underwriters of a proposed Underwritten Offering of the Registrable Securities included in a Shelf Registration advise the Board of Directors in writing that, in its or their opinion, the number of securities requested to be included
in an Underwritten Shelf Takedown exceeds the number which can be sold in such Underwritten Shelf Takedown without being likely to have a significant adverse effect on the price, timing or distribution of the securities offered or the market for the
securities offered, the number of Registrable Securities to be included in such offering shall be allocated pro rata among the Holders seeking to participate in such Underwritten Shelf Takedown (based on the relative number of Registrable Securities
requested to be included in such Underwritten Shelf Takedown), to the extent necessary to reduce the total number of Registrable Securities to be included in such Underwritten Shelf Takedown to the number recommended by the managing underwriter or
underwriters. 
 (h) In the event that a Holder requests to participate in a Registration pursuant to this Section 4.2 in connection
with a distribution of Registrable Securities to its partners or members, the Registration shall provide for resale by such partners or members, if requested by the Holder. 

Section 4.3 Piggyback Registration. 

(a) Participation. If the Company at any time proposes to file a Registration Statement under the Securities Act with respect to any
offering of its equity securities for its own account or for the account of any other Persons (other than (i) a Registration under Section 4.1 or 4.2, (ii) a Registration on Form S-4 or S-8 or any successor form to such Forms or
(iii) a Registration of securities solely relating to an offering and sale to employees or directors of the Company pursuant to any employee stock plan or other employee benefit plan arrangement (an “Issuer Public Sale”)),
then, as soon as practicable (but in no event less than fifteen (15) days prior to the proposed date of filing such Registration Statement), the Company shall give written notice (a “Piggyback Notice”) of such proposed filing
to all the Holders of Registrable Securities, and such notice shall offer the Holders of Registrable Securities the opportunity to Register under such Registration Statement such number of Registrable Securities as each such Holder may request in
writing (a “Piggyback Registration”). Subject to Section 4.3(b), the Company shall include in such Registration Statement all such Registrable Securities which are requested to be included therein within three (3) Business
Days after the receipt by such Holder of any such notice; provided, however, that if at any time after giving written notice of its intention to Register any securities and prior to the effective date of the Registration Statement
filed in connection with such Registration, the Company shall determine for any reason not to Register or to delay Registration of such securities, the Company shall give written notice of such determination to each Holder of Registrable Securities
and, thereupon, (i) in the case of a determination not to Register, shall be relieved of its obligation to Register any Registrable Securities in connection with such Registration (but not from its obligation to pay the Registration Expenses in
connection therewith), without prejudice, however, to the rights of any Holders of Registrable Securities entitled to request that such Registration be effected as a Demand Registration under Section 4.1, and (ii) in the case of a
determination to delay Registering, in the absence of a request for a Demand Registration, shall be permitted to delay Registering any Registrable Securities, for the same period as the delay in Registering such other securities. If the offering
pursuant to such Registration Statement is to be underwritten, then 

  
 18 

 
each Holder making a request for a Piggyback Registration pursuant to this Section 4.3(a) must, and the Company shall make such arrangements with the managing underwriter or underwriters so
that each such Holder may, participate in such Underwritten Offering. If the offering pursuant to such Registration Statement is to be on any other basis, then each Holder making a request for a Piggyback Registration pursuant to this
Section 4.3(a) must, and the Company shall make such arrangements so that each such Holder may, participate in such offering on such basis. Any Holder shall have the right to withdraw all or part of its request for inclusion of its Registrable
Securities in a Piggyback Registration by giving written notice to the Company of its request to withdraw; provided that such request must be made in writing prior to the effectiveness of such Registration Statement. 

(b) Priority of Piggyback Registration. If the managing underwriter or underwriters of any proposed Underwritten Offering of
Registrable Securities included in a Piggyback Registration informs the Company and the participating Holders of Registrable Securities in writing that, in its or their opinion, the number of securities which such Holders and any other Persons
intend to include in such offering exceeds the number which can be sold in such offering without being likely to have a significant adverse effect on the price, timing or distribution of the securities offered or the market for the securities
offered, then the securities to be included in such Registration shall be (i) first, one hundred percent (100%) of the securities that the Company or (subject to Section 4.7) any Person (other than a Holder of Registrable Securities)
exercising a contractual right to demand Registration, as the case may be, proposes to sell, and (ii) second, and only if all the securities referred to in clause (i) have been included, the number of Registrable Securities that, in the
opinion of such managing underwriter or underwriters, can be sold without having such adverse effect, with such number to be allocated pro rata among the Holders that have requested to participate in such Registration based on the
relative number of Registrable Securities requested to be included therein then held by each such Holder and (iii) third, and only if all of the Registrable Securities referred to in clause (ii) have been included in such Registration, any
other securities eligible for inclusion in such Registration. 
 (c) No Effect on Demand Registrations. No Registration of
Registrable Securities effected pursuant to a request under this Section 4.3 shall be deemed to have been effected pursuant to Sections 4.1 and 4.2 or shall relieve the Company of its obligations under Sections 4.1 or 4.2. 

Section 4.4 Black-out Periods. 

(a) Black-out Periods for Issuer Public Sales. In the event of an Issuer Public Sale of the Company’s equity securities in an
Underwritten Offering, the Holders of Registrable Securities agree, if requested by the managing underwriter or underwriters in such Underwritten Offering, not to effect any public sale or distribution of any securities (except, in each case, as
part of the applicable Registration, if permitted) that are the same as or similar to those being Registered in connection with such Issuer Public Sale, or any securities convertible into or exchangeable or exercisable for such securities, and agree
to become bound by and execute and deliver a lock-up agreement with respect to such restrictions, during the period beginning seven (7) days before and ending ninety (90) days (or such lesser periods as may be permitted by the Company or
such managing underwriter or underwriters) after, the date of the final Prospectus 

  
 19 

 
relating to such Underwritten Offering, to the extent timely notified in writing by the Company or the managing underwriter or underwriters; provided that such restrictions shall not apply
to (i) securities acquired in the public market subsequent to the Underwritten Offering, (ii) distributions-in-kind to a Holder’s partners or members or (iii) Transfers to Affiliates, but only if such Affiliates agree to be bound
by the restrictions herein. 
 (b) Black-out Period for Demand and Shelf Registrations. In the case of a Registration of Registrable
Securities pursuant to Section 4.1 or 4.2 for an Underwritten Offering, the Company and each Holder of Registrable Securities shall, if requested by the Demanding Holders holding a majority of the Demanding Holders’ Registrable Securities
to be included in such Registration or the managing underwriter or underwriters, not effect any public sale or distribution of any securities which are the same as or similar to those being Registered, or any securities convertible into or
exchangeable or exercisable for such securities, and, in the case of each such Holder, agree to become bound by and execute and deliver a lock-up agreement with respect to such restrictions, during the period beginning seven (7) days before,
and ending ninety (90) days (or such lesser periods as may be permitted by such Demanding Holders or such managing underwriter or underwriters) after, the date of the final Prospectus relating to such Underwritten Offering, to the extent timely
notified in writing by a Holder of Registrable Securities covered by such Registration Statement or the managing underwriter or underwriters. Notwithstanding the foregoing, the Company may effect a public sale or distribution of securities of the
type described above and during the periods described above if such sale or distribution is made pursuant to Registrations on Form S-4 or S-8 or any successor form to such Forms or as part of any Registration of securities for offering and sale to
employees or directors of the Company pursuant to any employee stock plan or other employee benefit plan arrangement. If requested by such Demanding Holders or such managing underwriter or underwriters, the Company shall use its reasonable best
efforts to obtain from each Holder of restricted securities of the Company which securities are the same as or similar to the Registrable Securities being Registered, or any restricted securities convertible into or exchangeable or exercisable for
any of such securities, an agreement not to effect any public sale or distribution of such securities during any such period referred to in this paragraph, except as part of any such Registration, if permitted. Notwithstanding the foregoing, with
respect to Holders of Registrable Securities, the restrictions set forth in this Section 4.4(b) shall not apply to (i) securities acquired in the public market subsequent to the Underwritten Offering, (ii) distributions-in-kind to a
Holder’s partners or members or (iii) Transfers to Affiliates, but only if such Affiliates agree to be bound by the restrictions herein. Without limiting the foregoing (but subject to Section 4.7), if after the date hereof the Company
grants any Person (other than a Holder of Registrable Securities) any rights to demand or participate in a Registration, the Company agrees that the agreement with respect thereto shall include such Person’s agreement to comply with any
black-out period required by this Section 4.4 as if it were a Holder hereunder). 
 Section 4.5 Registration Procedures.

 (a) In connection with the Company’s Registration obligations under Sections 4.1, 4.2 and 4.3, the Company shall use its reasonable
best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended method or methods of distribution thereof as expeditiously as reasonably practicable, and in connection therewith the Company
shall: 
 (i) prepare the required Registration Statement including all exhibits and financial statements required under the
Securities Act to be filed therewith, and before filing a Registration Statement, Prospectus or any Issuer Free Writing Prospectus, or any amendments or supplements thereto, (x) furnish to the underwriters, if any, and to the Holders of the
Registrable Securities covered by such Registration Statement, copies of all documents prepared to be filed, which documents shall be subject to the review of such underwriters and such Holders and their respective counsel and (y) except in the
case of a Registration under Section 4.3, not file any Registration Statement, Prospectus or any Issuer Free Writing Prospectus or amendments or supplements thereto to which the Holders of a majority of Registrable Securities, or any Sponsor
with Registrable Securities, covered by such Registration Statement or the underwriters, if any, shall reasonably object; 

  
 20 

 (ii) as soon as reasonably practicable file with the SEC a Registration Statement
relating to the Registrable Securities including all exhibits and financial statements required by the SEC to be filed therewith, and use its reasonable best efforts to cause such Registration Statement to become effective under the Securities Act
as soon as practicable; 
 (iii) prepare and file with the SEC such amendments and post-effective amendments to such
Registration Statement and supplements to the Prospectus or any Issuer Free Writing Prospectus as may be (x) reasonably requested by the Holders of a majority of participating Registrable Securities or by any Sponsor with Registrable Securities
covered by such Registration Statement, (y) reasonably requested by any participating Holder (to the extent such request relates to information relating to such Holder), or (z) necessary to keep such Registration effective for the period
of time required by this Agreement, and comply with provisions of the applicable securities laws with respect to the sale or other disposition of all securities covered by such Registration Statement during such period in accordance with the
intended method or methods of disposition by the sellers thereof set forth in such Registration Statement; 
 (iv) notify the
participating Holders of Registrable Securities and the managing underwriter or underwriters, if any, and (if requested) confirm such notice in writing and provide copies of the relevant documents, as soon as reasonably practicable after notice
thereof is received by the Company (a) when the applicable Registration Statement or any amendment thereto has been filed or becomes effective, and when the applicable Prospectus, any amendment or supplement to such Prospectus, any Issuer Free
Writing Prospectus or any amendment or supplement to such Issuer Free Writing Prospectus has been filed, (b) of any written comments by the SEC or any request by the SEC or any other federal or state governmental authority for amendments or
supplements to such Registration Statement, such Prospectus, such Issuer Free Writing Prospectus or for additional information (whether before or after the effective date of the Registration Statement), (c) of the issuance by the SEC of any
stop order suspending the effectiveness of such Registration Statement or any order by the SEC or any other regulatory authority preventing or suspending the use of any preliminary or final Prospectus or the initiation or threatening of any
proceedings for such purposes, (d) if, at any time, the representations and warranties of the Company in any applicable underwriting agreement 

  
 21 

 
cease to be true and correct in all material respects, and (e) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable
Securities for offering or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; 

(v) promptly notify each selling Holder of Registrable Securities and the managing underwriter or underwriters, if any, when
the Company becomes aware of the happening of any event as a result of which the applicable Registration Statement or the Prospectus included in such Registration Statement (as then in effect) or any Issuer Free Writing Prospectus contains any
untrue statement of a material fact or omits to state a material fact necessary to make the statements therein (in the case of such Prospectus, any preliminary Prospectus or Issuer Free Writing Prospectus, in light of the circumstances under which
they were made) not misleading, when any Issuer Free Writing Prospectus includes information that may conflict with the information contained in the Registration Statement, or, if for any other reason it shall be necessary during such time period to
amend or supplement such Registration Statement, Prospectus or Issuer Free Writing Prospectus in order to comply with the Securities Act and, in either case as promptly as reasonably practicable thereafter, prepare and file with the SEC, and furnish
without charge to the selling Holders and the managing underwriter or underwriters, if any, an amendment or supplement to such Registration Statement, Prospectus or Issuer Free Writing Prospectus which shall correct such misstatement or omission or
effect such compliance; 
 (vi) use its reasonable best efforts to prevent, or obtain the withdrawal of, any stop order or
other order or notice preventing or suspending the use of any preliminary or final Prospectus or any Issuer Free Writing Prospectus; 

(vii) promptly incorporate in a Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment such
information as the managing underwriter or underwriters and the Holders of a majority of Registrable Securities being sold agree should be included therein relating to the plan of distribution with respect to such Registrable Securities; and make
all required filings of such Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment as soon as reasonably practicable after being notified of the matters to be incorporated in such Prospectus supplement, Issuer Free
Writing Prospectus or post-effective amendment; 
 (viii) furnish to each selling Holder of Registrable Securities and each
underwriter, if any, without charge, as many conformed copies as such Holder or underwriter may reasonably request of the applicable Registration Statement and any amendment or post-effective amendment thereto, including financial statements and
schedules, all documents incorporated therein by reference and all exhibits (including those incorporated by reference); 

(ix) deliver to each selling Holder of Registrable Securities and each underwriter, if any, without charge, as many copies of
the applicable Prospectus (including each preliminary Prospectus) and any amendment or supplement thereto, each Issuer Free Writing Prospectus and such other documents as such Holder or underwriter 

  
 22 

 
may reasonably request in order to facilitate the disposition of the Registrable Securities by such Holder or underwriter (it being understood that the Company shall consent to the use of such
Prospectus or any Issuer Free Writing Prospectus or any amendment or supplement thereto by each of the selling Holders of Registrable Securities and the underwriters, if any, in connection with the offering and sale of the Registrable Securities
covered by such Prospectus or any amendment or supplement thereto or Issuer Free Writing Prospectus); 
 (x) on or prior to
the date on which the applicable Registration Statement becomes effective, use its reasonable best efforts to register or qualify, and cooperate with the selling Holders of Registrable Securities, the managing underwriter or underwriters, if any,
and their respective counsel, in connection with the registration or qualification of such Registrable Securities for offer and sale under the securities or “Blue Sky” laws of each state and other jurisdiction of the United States as any
such selling Holder or managing underwriter or underwriters, if any, or their respective counsel reasonably request in writing and do any and all other acts or things reasonably necessary or advisable to keep such registration or qualification in
effect for such period as required by Section 4.1(d) or Section 4.2(b), as applicable, provided that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified or to
take any action which would subject it to taxation or general service of process in any such jurisdiction where it is not then so subject; 

(xi) if requested, cooperate with the selling Holders of Registrable Securities and the managing underwriter or underwriters,
if any, to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends; and enable such Registrable Securities to be in such denominations and registered in
such names as the managing underwriters may request at least two (2) Business Days prior to any sale of Registrable Securities to the underwriters; 

(xii) use its reasonable best efforts to cause the Registrable Securities covered by the applicable Registration Statement to
be registered with or approved by such other governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter or underwriters, if any, to consummate the disposition of such Registrable Securities;

 (xiii) if requested, not later than the effective date of the applicable Registration Statement, provide a CUSIP number
for all Registrable Securities and provide the applicable transfer agent with printed certificates for the Registrable Securities which are in a form eligible for deposit with The Depository Trust Company; 

(xiv) make such representations and warranties to the Holders of Registrable Securities being registered, and the underwriters
or agents, if any, in form, substance and scope as are customarily made by issuers in underwritten public offerings similar to the offering then being undertaken; 

(xv) enter into such customary agreements (including underwriting and indemnification agreements) and take all such other
actions as the Holders of at least a 

  
 23 

 
majority of any Registrable Securities being sold, any participating Sponsor or the managing underwriter or underwriters, if any, reasonably request in order to expedite or facilitate the
registration and disposition of such Registrable Securities; 
 (xvi) obtain for delivery to the Holders of Registrable
Securities being registered and to the underwriter or underwriters, if any, an opinion or opinions from counsel for the Company dated the most recent effective date of the Registration Statement or, in the event of an Underwritten Offering, the date
of the closing under the underwriting agreement, in customary form, scope and substance, which opinions shall be reasonably satisfactory to such Holders or underwriters, as the case may be, and their respective counsel; 

(xvii) in the case of an Underwritten Offering, obtain for delivery to the Company and the managing underwriter or
underwriters, with copies to the Holders of Registrable Securities included in such Registration, a cold comfort letter from the Company’s independent certified public accountants (and, if necessary, any other independent certified public
accountants of any subsidiary of the Company or any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement) in customary form and covering such matters of
the type customarily covered by cold comfort letters as the managing underwriter or underwriters reasonably request, dated the date of execution of the underwriting agreement and brought down to the closing under the underwriting agreement; 

(xviii) cooperate with each seller of Registrable Securities and each underwriter, if any, participating in the disposition of
such Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; 

(xix) use its reasonable best efforts to comply with all applicable securities laws and make available to its security holders,
as soon as reasonably practicable, an earnings statement satisfying the provisions of Section 11(a) of the Securities Act and the rules and regulations promulgated thereunder; 

(xx) provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by the applicable
Registration Statement from and after a date not later than the effective date of such Registration Statement; 
 (xxi) use
its best efforts to cause all Registrable Securities covered by the applicable Registration Statement to be listed on each securities exchange on which any of the Company’s equity securities are then listed or quoted and on each inter-dealer
quotation system on which any of the Company’s equity securities are then quoted; 
 (xxii) make available upon
reasonable notice at reasonable times and for reasonable periods for inspection by a representative appointed by the majority of the Holders of Registrable Securities covered by the applicable Registration Statement, by any underwriter participating
in any disposition to be effected pursuant to such Registration Statement and by any attorney, accountant or other agent retained by such 

  
 24 

 
Holders or any such underwriter, all pertinent financial and other records, pertinent corporate documents and properties of the Company, and cause all of the Company’s officers, directors
and employees and the independent public accountants who have certified its financial statements to make themselves available to discuss the business of the Company and to supply all information reasonably requested by any such Person in connection
with such Registration Statement as shall be necessary to enable them to exercise their due diligence responsibility; provided, however, that any such Person gaining access to information regarding the Company pursuant to this
Section 4.5(a)(xxii) shall agree to hold in strict confidence and shall not make any disclosure or use any information regarding the Company which the Company determines in good faith to be confidential, and of which determination such Person
is notified, unless (v) the release of such information is requested or required (by deposition, interrogatory, requests for information or documents by a governmental entity, subpoena or similar process), (w) disclosure of such
information, in the opinion of counsel to such Person, is otherwise required by law, (x) such information is or becomes publicly known other than through a breach of this or any other agreement of which such Person has knowledge, (y) such
information is or becomes available to such Person on a non-confidential basis from a source other than the Company or (z) such information is independently developed by such Person; 

(xxiii) in the case of a marketed Underwritten Offering, cause the senior executive officers of the Company to participate in
the customary “road show” presentations that may be reasonably requested by the managing underwriter or underwriters in any such Underwritten Offering and otherwise to facilitate, cooperate with, and participate in each proposed offering
contemplated herein and customary selling efforts related thereto; 
 (xxiv) take no direct or indirect action prohibited by
Regulation M under the Exchange Act; 
 (xxv) take all reasonable action to ensure that any Issuer Free Writing Prospectus
utilized in connection with any registration covered by Section 4.1, 4.2 or 4.3 complies in all material respects with the Securities Act, is filed in accordance with the Securities Act to the extent required thereby, is retained in accordance
with the Securities Act to the extent required thereby and, when taken together with the related Prospectus, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading; and 
 (xxvi) take all such other commercially reasonable
actions as are necessary or advisable in order to expedite or facilitate the disposition of such Registrable Securities. 
 (b) To the
extent the Company is eligible under the relevant provisions of Rule 430B under the Securities Act, if the Company files any Shelf Registration Statement, the Company shall include in such Shelf Registration Statement such disclosures as may be
required by Rule 430B under the Securities Act (referring to the unnamed selling security holders in a generic manner by identifying the initial offering of the securities to the Holders) in order to ensure that the Holders may be added to such
Shelf Registration Statement at a later time through the filing of a Prospectus supplement rather than a post-effective amendment. 

  
 25 

 (c) The Company may require each seller of Registrable Securities as to which any Registration is
being effected to furnish to the Company such information regarding the distribution of such securities and such other information relating to such Holder and its ownership of Registrable Securities as the Company may from time to time reasonably
request in writing and the Company may exclude from such registration the Registrable Securities of any such Holder who unreasonably fails to furnish such information within a reasonable time after receiving such request. Each Holder of Registrable
Securities agrees to furnish such information to the Company and to cooperate with the Company as reasonably necessary to enable the Company to comply with the provisions of this Agreement. 

(d) Each Holder of Registrable Securities agrees that, upon receipt of any notice from the Company of the happening of any event of the kind
described in Section 4.5(a)(v), such holder will forthwith discontinue disposition of Registrable Securities pursuant to such Registration Statement until such Holder’s receipt of the copies of the supplemented or amended Prospectus or
Issuer Free Writing Prospectus, as the case may be, contemplated by Section 4.5(a)(v), or until such Holder is advised in writing by the Company that the use of the Prospectus or Issuer Free Writing Prospectus, as the case may be, may be
resumed, and has received copies of any additional or supplemental filings that are incorporated by reference in the Prospectus or such Issuer Free Writing Prospectus or any amendments or supplements thereto and if so directed by the Company, such
Holder shall deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in such Holder’s possession, of the Prospectus or any Issuer Free Writing Prospectus covering such Registrable Securities
current at the time of receipt of such notice. In the event the Company shall give any such notice, the period during which the applicable Registration Statement is required to be maintained effective shall be extended by the number of days during
the period from and including the date of the giving of such notice to and including the date when each seller of Registrable Securities covered by such Registration Statement either receives the copies of the supplemented or amended Prospectus or
such Issuer Free Writing Prospectus contemplated by Section 4.5(a)(v) or is advised in writing by the Company that the use of the Prospectus may be resumed. 

(e) If any Registration Statement or comparable statement under the “Blue Sky” laws refers to any Holder by name or otherwise as the
Holder of any securities of the Company, then such Holder shall have the right to require (i) the insertion therein of language, in form and substance satisfactory to such Holder and the Company, to the effect that the holding by such Holder of
such securities is not to be construed as a recommendation by such Holder of the investment quality of the Company’s securities covered thereby and that such holding does not imply that such Holder will assist in meeting any future financial
requirements of the Company, or (ii) in the event that such reference to such Holder by name or otherwise is not in the judgment of the Company, as advised by counsel, required by the Securities Act or any similar federal statute or any
“Blue Sky” or securities law then in force, the deletion of the reference to such Holder. 
 (f) Holders may seek to register
different types of Registrable Securities simultaneously and the Company shall use its reasonable best efforts to effect such Registration and sale in accordance with the intended method or methods of disposition specified by such Holders. 

  
 26 

 Section 4.6 Underwritten Offerings. 

(a) Shelf and Demand Registrations. If requested by the underwriters for any Underwritten Offering requested by Holders of Registrable
Securities pursuant to a Registration under Section 4.1 or Section 4.2, the Company shall enter into an underwriting agreement with such underwriters for such offering, such agreement to be reasonably satisfactory in substance and form to
the Company, participating Sponsor Demand Holders and the underwriters, and to contain such representations and warranties by the Company and such other terms as are generally prevailing in agreements of that type, including indemnities no less
favorable to the recipient thereof than those provided in Section 4.9. The Holders of the Registrable Securities proposed to be distributed by such underwriters shall cooperate with the Company in the negotiation of the underwriting agreement
and shall give consideration to the reasonable suggestions of the Company regarding the form thereof. Such Holders of Registrable Securities to be distributed by such underwriters shall be parties to such underwriting agreement, which underwriting
agreement shall (i) contain such representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of such Holders of Registrable Securities as are customarily made by issuers to selling stockholders
in underwritten public offerings similar to the applicable Underwritten Offering and (ii) provide that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement also shall be conditions
precedent to the obligations of such Holders of Registrable Securities. Any such Holder of Registrable Securities shall not be required to make any representations or warranties to or agreements with the Company or the underwriters other than
representations, warranties or agreements regarding such Holder, such Holder’s title to the Registrable Securities, such Holder’s intended method of distribution and any other representations required to be made by the Holder under
applicable law, and the aggregate amount of the liability of such Holder shall not exceed such Holder’s net proceeds from such Underwritten Offering. 

(b) Piggyback Registrations. If the Company proposes to register any of its securities under the Securities Act as contemplated by
Section 4.3 and such securities are to be distributed in an Underwritten Offering through one or more underwriters, the Company shall, if requested by any Holder of Registrable Securities pursuant to Section 4.3 and subject to the
provisions of Sections 4.3(b), use its reasonable best efforts to arrange for such underwriters to include on the same terms and conditions that apply to the other sellers in such Registration all the Registrable Securities to be offered and sold by
such Holder among the securities of the Company to be distributed by such underwriters in such Registration. The Holders of Registrable Securities to be distributed by such underwriters shall be parties to the underwriting agreement between the
Company and such underwriters, which underwriting agreement shall (i) contain such representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of such Holders of Registrable Securities as are
customarily made by issuers to selling stockholders in secondary underwritten public offerings and (ii) provide that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement also shall be
conditions precedent to the obligations of such Holders of Registrable Securities. Any such Holder of Registrable Securities shall not be required to make any representations or warranties to or agreements with the Company or the

  
 27 

 
underwriters other than representations, warranties or agreements regarding such Holder, such Holder’s title to the Registrable Securities and such Holder’s intended method of
distribution or any other representations required to be made by the Holder under applicable law, and the aggregate amount of the liability of such Holder shall not exceed such Holder’s net proceeds from such Underwritten Offering. 

(c) Participation in Underwritten Registrations. Subject to the provisions of Section 4.6(a) and (b) above, no Person may
participate in any Underwritten Offering hereunder unless such Person (i) agrees to sell such Person’s securities on the basis provided in any underwriting arrangements approved by the Persons entitled to approve such arrangements and
(ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents required under the terms of such underwriting arrangements. 

(d) Price and Underwriting Discounts. In the case of an Underwritten Offering under Section 4.1 or 4.2, the price, underwriting
discount and other financial terms for the Registrable Securities shall be determined by the participating Sponsor Demand Holders. In addition, in the case of any Underwritten Offering, subject to Section 4.2(f)(ii), each of the Holders may
withdraw their request to participate in the Registration pursuant to Section 4.1, 4.2 or 4.3 after being advised of such price, discount and other terms and shall not be required to enter into any agreements or documentation that would require
otherwise. 
 Section 4.7 No Inconsistent Agreements; Additional Rights. The Company shall not hereafter enter into, and is not
currently a party to, any agreement with respect to its securities which is inconsistent with the rights granted to the Holders of Registrable Securities by this Agreement. Without the consent of the Qualifying Shareholders, the Company shall not
enter into any agreement granting registration or similar rights to any Person, and hereby represents and warrants that, as of the date hereof, no registration or similar rights have been granted to any other Person other than pursuant to this
Agreement and the Management Registration Rights Agreement. 
 Section 4.8 Registration Expenses. All expenses incident to the
Company’s performance of or compliance with this Agreement shall be paid by the Company, including (i) all registration and filing fees, and any other fees and expenses associated with filings required to be made with the SEC or FINRA,
(ii) all fees and expenses in connection with compliance with any securities or “Blue Sky” laws, (iii) all printing, duplicating, word processing, messenger, telephone, facsimile and delivery expenses (including expenses of
printing certificates for the Registrable Securities in a form eligible for deposit with The Depository Trust Company and of printing Prospectuses and Issuer Free Writing Prospectuses), (iv) all fees and disbursements of counsel for the Company
and of all independent certified public accountants of the Company (including the expenses of any special audit and cold comfort letters required by or incident to such performance), (v) Securities Act liability insurance or similar insurance
if the Company so desires or the underwriters so require in accordance with then-customary underwriting practice, (vi) all fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange or
quotation of the Registrable Securities on any inter-dealer quotation system, (vii) all applicable rating agency fees with respect to the Registrable Securities, (viii) all reasonable fees and disbursements of legal counsel for each
Sponsor participating in such Registration, (ix) all fees and expenses of accountants 

  
 28 

 
selected by the Holders of a majority of the Registrable Securities being registered, (x) any reasonable fees and disbursements of underwriters customarily paid by issuers or sellers of
securities, (xi) all fees and expenses of any special experts or other Persons retained by the Company in connection with any Registration, (xii) all of the Company’s internal expenses (including all salaries and expenses of its
officers and employees performing legal or accounting duties) and (xiii) all expenses related to the “road-show” for any Underwritten Offering, including all travel, meals and lodging. All such expenses are referred to herein as
“Registration Expenses.” The Company shall not be required to pay any fees and disbursements to underwriters not customarily paid by issuers, including underwriting discounts and commissions and transfer taxes, if any, attributable
to the sale of Registrable Securities. 
 Section 4.9 Indemnification. 

(a) Indemnification by the Company. The Company shall indemnify and hold harmless, to the full extent permitted by law, each Holder of
Registrable Securities, each shareholder, member, limited or general partner thereof, each shareholder, member, limited or general partner of each such shareholder, member, limited or general partner, each of their respective Affiliates, officers,
directors, shareholders, employees, advisors, and agents and each Person who controls (within the meaning of the Securities Act or the Exchange Act) such Persons and each of their respective Representatives from and against any and all losses,
penalties, judgments, suits, costs, claims, damages, liabilities and expenses, joint or several (including reasonable costs of investigation and legal expenses) (each, a “Loss” and collectively “Losses”) arising out
of or based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement under which such Registrable Securities were Registered under the Securities Act (including any final, preliminary or summary
Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein), or any other disclosure document produced by or on behalf of the Company or any of its subsidiaries including, without
limitation, reports and other documents filed under the Exchange Act or any Issuer Free Writing Prospectus or amendment thereof or supplement thereto, (ii) any omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus or any Issuer Free Writing Prospectus in light of the circumstances under which they were made) not misleading or (iii) any actions or
inactions or proceedings in respect of the foregoing whether or not such indemnified party is a party thereto. This indemnity shall be in addition to any liability the Company may otherwise have. Such indemnity shall remain in full force and effect
regardless of any investigation made by or on behalf of such Holder or any indemnified party and shall survive the Transfer of such securities by such Holder. The Company shall also indemnify underwriters, selling brokers, dealer managers and
similar securities industry professionals participating in the distribution, their officers and directors and each Person who controls such Persons (within the meaning of the Securities Act and the Exchange Act) to the same extent as provided above
with respect to the indemnification of the indemnified parties. 
 (b) Indemnification by the Selling Holder of Registrable
Securities. Each selling Holder of Registrable Securities agrees (severally and not jointly) to indemnify and hold harmless, to the fullest extent permitted by law, the Company, its directors and officers and each Person who controls the Company
(within the meaning of the Securities Act or the Exchange 

  
 29 

 
Act) from and against any Losses resulting from (i) any untrue statement of a material fact in any Registration Statement under which such Registrable Securities were Registered under the
Securities Act (including any final, preliminary or summary Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein or any Issuer Free Writing Prospectus or amendment thereof or
supplement thereto), or (ii) any omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus or any Issuer Free Writing Prospectus, in
light of the circumstances under which they were made) not misleading, to the extent, but only to the extent, that such untrue statement or omission is contained in any information furnished in writing by such selling Holder to the Company
specifically for inclusion in such Registration Statement and has not been corrected in a subsequent writing prior to or concurrently with the sale of the Registrable Securities to the Person asserting the claim. In no event shall the liability of
any selling Holder of Registrable Securities hereunder be greater in amount than the dollar amount of the net proceeds received by such Holder under the sale of Registrable Securities giving rise to such indemnification obligation less any amounts
paid by such Holder pursuant to Section 4.9(d). The Company shall be entitled to receive indemnities from underwriters, selling brokers, dealer managers and similar securities industry professionals participating in the distribution, to the
same extent as provided above (with appropriate modification) with respect to information furnished in writing by such Persons specifically for inclusion in any Prospectus or Registration Statement. 

(c) Conduct of Indemnification Proceedings. Any Person entitled to indemnification hereunder shall (i) give prompt written notice
to the indemnifying party of any claim with respect to which it seeks indemnification (provided that any delay or failure to so notify the indemnifying party shall relieve the indemnifying party of its obligations hereunder only to the
extent, if at all, that it is actually and materially prejudiced by reason of such delay or failure) and (ii) permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party;
provided, however, that any Person entitled to indemnification hereunder shall have the right to select and employ separate counsel and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at
the expense of such Person unless (i) the indemnifying party has agreed in writing to pay such fees or expenses, (ii) the indemnifying party shall have failed to assume the defense of such claim within a reasonable time after receipt of
notice of such claim from the Person entitled to indemnification hereunder and employ counsel reasonably satisfactory to such Person, (iii) the indemnified party has reasonably concluded (based upon advice of its counsel) that there may be
legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, or (iv) in the reasonable judgment of any such Person (based upon advice of its counsel) a conflict
of interest may exist between such Person and the indemnifying party with respect to such claims (in which case, if the Person notifies the indemnifying party in writing that such Person elects to employ separate counsel at the expense of the
indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such Person). If the indemnifying party assumes the defense, the indemnifying party shall not have the right to settle such action
without the consent of the indemnified party. No indemnifying party shall consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
indemnified party of an unconditional release from all liability in respect to such claim or litigation without the prior written consent of such indemnified party. If 

  
 30 

 
such defense is not assumed by the indemnifying party, the indemnifying party will not be subject to any liability for any settlement made without its prior written consent, but such consent may
not be unreasonably withheld. It is understood that the indemnifying party or parties shall not, except as specifically set forth in this Section 4.9(c), in connection with any proceeding or related proceedings in the same jurisdiction, be
liable for the reasonable fees, disbursements or other charges of more than one separate firm admitted to practice in such jurisdiction at any one time unless (x) the employment of more than one counsel has been authorized in writing by the
indemnifying party or parties, (y) an indemnified party has reasonably concluded (based on the advice of counsel) that there may be legal defenses available to it that are different from or in addition to those available to the other
indemnified parties or (z) a conflict or potential conflict exists or may exist (based upon advice of counsel to an indemnified party) between such indemnified party and the other indemnified parties, in each of which cases the indemnifying
party shall be obligated to pay the reasonable fees and expenses of such additional counsel or counsels. 
 (d) Contribution. If for
any reason the indemnification provided for in paragraphs (a) and (b) of this Section 4.9 is unavailable to an indemnified party (other than as a result of exceptions contained in paragraphs (a) and (b) of this
Section 4.9) or insufficient in respect of any Losses referred to therein, then the indemnifying party shall contribute to the amount paid or payable by the indemnified party as a result of such Loss in such proportion as is appropriate to
reflect the relative fault of the indemnifying party on the one hand and the indemnified party or parties on the other hand in connection with the acts, statements or omissions that resulted in such Losses, as well as any other relevant equitable
considerations. In connection with any Registration Statement filed with the SEC by the Company, the relative fault of the indemnifying party on the one hand and the indemnified party on the other hand shall be determined by reference to, among
other things, whether any untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be just or equitable if contribution pursuant to this Section 4.9(d) were determined
by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in this Section 4.9(d). No Person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. The amount paid or payable by an indemnified party as a result of the Losses referred to in
Sections 4.9(a) and 4.9(b) shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this Section 4.9(d), in connection with any Registration Statement filed by the Company, a selling Holder of Registrable Securities shall not be required to contribute any amount in excess of the dollar amount
of the net proceeds received by such holder under the sale of Registrable Securities giving rise to such contribution obligation less any amounts paid by such Holder pursuant to Section 4.9(b). If indemnification is available under this
Section 4.9, the indemnifying parties shall indemnify each indemnified party to the full extent provided in Sections 4.9(a) and 4.9(b) hereof without regard to the provisions of this Section 4.9(d). The remedies provided for in this
Section 4.9 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity. 

  
 31 

 Section 4.10 Rules 144 and 144A and Regulation S. The Company shall file the
reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the request of any Holder of
Registrable Securities, make publicly available such necessary information for so long as necessary to permit sales that would otherwise be permitted by this Agreement pursuant to Rule 144, Rule 144A or Regulation S under the Securities Act, as such
Rules may be amended from time to time or any similar rule or regulation hereafter adopted by the SEC), and it will take such further action as any Holder of Registrable Securities may reasonably request, all to the extent required from time to time
to enable such Holder to sell Registrable Securities without Registration under the Securities Act in transactions that would otherwise be permitted by this Agreement and within the limitation of the exemptions provided by (i) Rules 144, 144A
or Regulation S under the Securities Act, as such Rules may be amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder of Registrable Securities, the Company will deliver to
such Holder a written statement as to whether it has complied with such requirements and, if not, the specifics thereof. 

Section 4.11 Termination. The registration rights provided for in this Article IV shall terminate upon the expiration of the Shelf
Period, except for the provisions of Sections 4.9 and 4.10, which shall survive any such termination. 
 Section 4.12 Existing
Registration Statements. Notwithstanding anything herein to the contrary and subject to applicable law and regulation, the Company may satisfy any obligation hereunder to file a Registration Statement or to have a Registration Statement become
effective by a specified date by designating, by notice to the Holders, a registration statement that previously has been filed with the SEC or become effective, as the case may be, as the relevant Registration Statement for purposes of satisfying
such obligation, and all references to any such obligation shall be construed accordingly; provided that such previously filed registration statement may be amended to add the number of Registrable Securities, and, to the extent necessary, to
identify as selling stockholders those Holders demanding the filing of a Registration Statement pursuant to the terms of this Agreement. To the extent this Agreement refers to the filing or effectiveness of other registration statements by or at a
specified time and the Company has, in lieu of then filing such registration statements or having such registration statements become effective, designated a previously filed or effective registration statement as the relevant registration statement
for such purposes in accordance with the preceding sentence, such references shall be construed to refer to such designated registration statement. 

  
 32 

 ARTICLE V 

GENERAL PROVISIONS 

Section 5.1 Assignment; Benefit. 

(a) The rights and obligations hereunder shall not be assignable without the prior written consent of the other parties hereto;
provided, that (i) the rights and obligations set forth in Article IV hereof may be assigned by a Sponsor in connection with a Transfer pursuant to Article III of the Coordination Agreement among the Sponsors, dated as of the date hereof
(as such agreement may be amended from time to time, the “Coordination Agreement”) or to a Permitted Transferee (as defined in the Coordination Agreement), and (ii) all rights and obligations hereunder may be assigned by a
Sponsor to its Permitted Transferees (as defined in the Coordination Agreement); provided that in the event of a partial assignment by a Sponsor, for purposes of the limitation under Section 4.1(b) with respect to the number of Long-Form
Registrations that a Sponsor Demand Holder has the right to request, such limitation shall apply to the transferring Sponsor and its assignees collectively such that the transferring Sponsor and its assignees collectively may not request more than
three (3) Long-Form Registrations hereunder. As a condition to such assignment, such assignee, if not a Holder, must deliver to the Company a written acknowledgment and agreement in form and substance reasonably satisfactory to the Company that
such assignee will be bound by, and will be a party to, this Agreement. Any such assignee may not again assign those rights, other than in accordance with this Section 5.1. Any attempted assignment of rights or obligations in violation of this
Section 5.1 shall be null and void. 
 (b) This Agreement shall be binding upon and shall inure to the benefit of the parties hereto,
and their respective successors and permitted assigns, and there shall be no third-party beneficiaries to this Agreement other than the indemnitees under Section 4.9 and Sponsor Directors under the first sentence of Section 3.1(l). 

Section 5.2 Freedom to Pursue Opportunities. The parties expressly acknowledge and agree that: (i) each Shareholder, Sponsor
Director and Affiliated Officer of the Company has the right to, and shall have no duty (contractual or otherwise) not to, (x) directly or indirectly engage in the same or similar business activities or lines of business as the Company or any
of its subsidiaries, including those deemed to be competing with the Company or any of their subsidiaries, or (y) directly or indirectly do business with any client or customer of the Company or any of its subsidiaries; and (ii) in the
event that a Shareholder, Sponsor Director or Affiliated Officer of the Company acquires knowledge of a potential transaction or matter that may be a corporate opportunity for the Company or any of its subsidiaries and such Shareholder or any other
Person, the Shareholder, Sponsor Director and Affiliated Officer of the Company shall have no duty (contractual or otherwise) to communicate or present such corporate opportunity to the Company or any of their subsidiaries, as the case may be, and,
notwithstanding any provision of this Agreement to the contrary, shall not be liable to the Company, its subsidiaries or their respective Affiliates or Shareholders for breach of any duty (contractual or otherwise) by reason of the fact that such
Shareholder, Sponsor Director or Affiliated Officer, directly or indirectly, pursues or acquires such opportunity for itself, directs such opportunity to another Person, or does not present such opportunity to the Company or any of its subsidiaries.

  
 33 

 Section 5.3 Preemptive Rights. Until the Trigger Date (as defined in the Articles),
in the event the Company proposes to issue additional Company Shares or other equity securities of the Company or any of its subsidiaries to any of the Sponsors, including any warrants, options or other rights to acquire Company Shares, equity
securities of the Company or any of its subsidiaries or debt securities that are convertible into Company Shares or equity securities of the Company or any of its subsidiaries, the Company and each such Sponsor agree to give reasonable notice and
opportunity to each other Sponsor to participate in such issuance on a pro rata basis. 
 Section 5.4 Termination. 

(a) Article III shall terminate automatically (without any action by any party hereto) as to each Shareholder upon the later of (i) the
time at which such Shareholder no longer has the right to designate an individual for nomination to the Board of Directors under this Agreement and (ii) the time at which the Shareholders cease to hold in aggregate at least fifty percent
(50%) of the outstanding shares of the Company’s common stock; provided, that the provisions in Sections 3.1(l), 3.3 and 3.4 shall survive such termination. Article IV of this Agreement shall terminate as set forth in
Section 4.11. The remainder of this Agreement shall terminate automatically (without any action by any party hereto) as to each Shareholder when such Shareholder ceases to hold any Company Shares. 

Section 5.5 Severability. In the event that any provision of this Agreement shall be invalid, illegal or unenforceable such
provision shall be construed by limiting it so as to be valid, legal and enforceable to the maximum extent provided by law and the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired
thereby. 
 Section 5.6 Entire Agreement; Amendment. (a) This Agreement (together with the Coordination Agreement and the
Management Registration Rights Agreement) sets forth the entire understanding and agreement between the parties with respect to the transactions contemplated herein and supersedes and replaces any prior understanding, agreement or statement of
intent, in each case written or oral, of any kind and every nature with respect hereto. No provision of this Agreement may be amended, modified or waived in whole or in part at any time without the express written consent of the Company and the
Shareholders holding in aggregate more than fifty percent (50%) of the Company Shares held by the Shareholders; provided that any such amendment, modification or waiver that (i) would be materially adverse in any respect to any
Qualifying Shareholder shall require the prior written consent of such Qualifying Shareholder or (ii) would be disproportionately adverse to any Sponsor relative to the Qualifying Shareholders (or, to the extent there are no Qualifying
Shareholders, relative to the other Sponsors) shall require the prior written consent of such disproportionately adversely affected Sponsor. Notwithstanding the foregoing, none of (A) the first two sentences of Section 3.1(l) relating to
Indemnification Agreements for Sponsor Directors, (B) the definition of Indemnification Agreement and (C) the form of Indemnification Agreement in Exhibit 1 shall be amended in any manner adverse to a Sponsor Director without the express
prior written consent of each Sponsor and the Company. Except as set forth above, there are no other agreements with respect to the governance of the Company between any Shareholders or any of their Affiliates. 

  
 34 

 (b) No waiver of any breach of any of the terms of this Agreement shall be effective unless such
waiver is expressly made in writing and executed and delivered by the party against whom such waiver is claimed. The waiver by any party hereto of a breach of any provision of this Agreement shall not operate or be construed as a further or
continuing waiver of such breach or as a waiver of any other or subsequent breach. Except as otherwise expressly provided herein, no failure on the part of any party to exercise, and no delay in exercising, any right, power or remedy hereunder, or
otherwise available in respect hereof at law or in equity, shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such party preclude any other or further exercise thereof or the exercise of any
other right, power or remedy. 
 Section 5.7 Counterparts. This Agreement may be executed in any number of separate counterparts
each of which when so executed shall be deemed to be an original and all of which together shall constitute one and the same agreement. 

  
 35 

 Section 5.8 Notices. Unless otherwise specified herein, all notices, consents,
approvals, reports, designations, requests, waivers, elections and other communications authorized or required to be given pursuant to this Agreement shall be in writing and shall be given, made or delivered by personal hand-delivery, by facsimile
transmission, by electronic mail, by mailing the same in a sealed envelope, registered first-class mail, postage prepaid, return receipt requested, or by air courier guaranteeing overnight delivery (and such notice shall be deemed to have been duly
given, made or delivered (a) on the date received, if delivered by personal hand delivery, (b) on the date received, if delivered by facsimile transmission, by electronic mail or by registered first-class mail prior to 5:00 p.m. prevailing
local time on a Business Day, or if delivered after 5:00 p.m. prevailing local time on a Business Day or on other than a Business Day, on the first Business Day thereafter and (c) two (2) Business Days after being sent by air courier
guaranteeing overnight delivery), addressed to the Shareholder at the following addresses (or at such other address for a Shareholder as shall be specified by like notice): 

if to TPG, to: 
 TPG Global, LLC

 301 Commerce Street 
 Suite
3300 
 Fort Worth, Texas 76102 

Attention: Ronald Cami 
 Fax:
(415) 743-1501 
 E-mail:            rcami@tpg.com 

with a copy (which shall not constitute notice) to: 

Ropes & Gray LLP 
 The
Prudential Tower 
 800 Boylston Street 

Boston, Massachusetts 02199 

Attention:        Alfred O. Rose 

                        
Amanda McGrady Morrison 
 Facsimile:       (617) 951-7050 

E-mail:            alfred.rose@ropesgray.com 

                        
amanda.morrison@ropesgray.com 
 if to CPPIB, to: 

c/o Canada Pension Plan Investment Board 

One Queen Street East 
 Suite
2700, P.O. Box 101 
 Toronto, Ontario M5C 2W5 

Canada 
 Attention: Andre
Bourbonnais 
 Fax: 416-868-8684 

E-mail: abourbonnais@cppib.ca 

  
 36 

 with a copy (which shall not constitute notice) to: 

Torys LLP 
 1114 Avenue of the
Americas 
 23rd Floor 
 New
York, New York 10036 
 Attention: Stefan P. Stauder 

Fax: 212-682-0200 
 E-mail:
spstauder@torys.com 
 if to LGP, to: 

Leonard Green & Partners 

11111 Santa Monica Boulevard Suite 2000 

Los Angeles, CA 90025 
 Attention:
John Baumer 
 Fax: 310-954-0404 

E-mail: baumer@leonardgreen.com 

with a copy (which shall not constitute notice) to: 

Latham & Watkins LLP 

885 Third Avenue 
 New York, NY
10022 
 Attention: Howard Sobel 

Fax: 212-751-4864 
 E-mail:
howard.sobel@lw.com 
 if to the Company to: 

IMS Health Holdings, Inc. 
 83
Wooster Road 
 Danbury, Connecticut 06810 

Attention: General Counsel 
 Fax:
203-845-5302 
 E-mail: Hashman@imshealth.com 

  
 37 

 with a copy (which shall not constitute notice) to: 

Ropes & Gray LLP 
 The
Prudential Tower 
 800 Boylston Street 

Boston, Massachusetts 02199 

Attention:        Alfred O. Rose 

                        
Amanda McGrady Morrison 
 Facsimile:       (617) 951-7050 

E-mail:            alfred.rose@ropesgray.com 

                        
amanda.morrison@ropesgray.com 
 Section 5.9 Governing Law. THIS AGREEMENT AND ANY RELATED DISPUTE SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE. 
 Section 5.10 Jurisdiction. ANY ACTION OR PROCEEDING AGAINST
THE PARTIES RELATING IN ANY WAY TO THIS AGREEMENT MAY BE BROUGHT EXCLUSIVELY IN THE COURTS OF THE STATE OF DELAWARE OR (TO THE EXTENT SUBJECT MATTER JURISDICTION EXISTS THEREFORE) THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE, AND
THE PARTIES IRREVOCABLY SUBMIT TO THE JURISDICTION OF BOTH SUCH COURTS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING. ANY ACTIONS OR PROCEEDINGS TO ENFORCE A JUDGMENT ISSUED BY ONE OF THE FOREGOING COURTS MAY BE ENFORCED IN ANY JURISDICTION. 

Section 5.11 Waiver of Jury Trial. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED, EACH SHAREHOLDER WAIVES,
AND COVENANTS THAT SUCH PARTY WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE, CLAIM OR PROCEEDING ARISING OUT OF THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY
WAY CONNECTED WITH THE DEALINGS OF ANY SHAREHOLDER OR THE COMPANY IN CONNECTION WITH ANY OF THE ABOVE, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING AND WHETHER IN CONTRACT, TORT OR OTHERWISE. The Company or any Shareholder may file an
original counterpart or a copy of this Section 5.11 with any court as written evidence of the consent of the Shareholders to the waiver of their rights to trial by jury. 

Section 5.12 Specific Performance. It is hereby agreed and acknowledged that it will be impossible to measure in money the damages
that would be suffered if the parties fail to comply with any of the obligations herein imposed on them by this Agreement and that, in the event of any such failure, an aggrieved party will be irreparably damaged and will not have an adequate remedy
at law. Any such party shall, therefore, be entitled (in addition to any other remedy to which such party may be entitled at law or in equity) to injunctive relief, including specific performance, to enforce such obligations, without the posting of
any bond, and if any action should be brought in equity to enforce any of the provisions of this Agreement, none of the parties hereto shall raise the defense that there is an adequate remedy at law. 

  
 38 

 Section 5.13 Subsequent Acquisition of Shares. Any equity securities of the Company
acquired subsequent to the date hereof by a Shareholder shall be subject to the terms and conditions of this Agreement and such shares shall be considered to be “Company Shares” as such term is used herein for purposes of this Agreement.

 [Signature Pages Follow] 

  
 39 

 IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the day and year first
above written. 
  

			
	IMS HEALTH HOLDINGS, INC.
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Stockholders Agreement] 

									
	TPG PARTNERS VI, L.P.	 		 	TPG FOF V-A, L.P.
					
	By:	 	TPG GenPar VI, L.P., its General Partner	 		 	By:	 	TPG GenPar V, L.P., its General Partner
					
	By:	 	TPG Advisors VI, Inc., its General Partner	 		 	By:	 	TPG Advisors V, Inc., its General Partner
					
	By:	 	  
	 		 	By:	 	  

		 	 Name: Ronald Cami
 Title:   Vice
President
	 		 		 	 Name: Ronald Cami
 Title:   Vice
President

			
	TPG PARTNERS V, L.P.	 		 	TPG FOF V-B, L.P.
					
	By:	 	TPG GenPar V, L.P., its General Partner	 		 	By:	 	TPG GenPar V, L.P., its General Partner
					
	By:	 	TPG Advisors V, Inc., its General Partner	 		 	By:	 	TPG Advisors V, Inc., its General Partner
					
	By:	 	  
	 		 	By:	 	  

		 	 Name: Ronald Cami
 Title:   Vice
President
	 		 		 	 Name: Ronald Cami
 Title:   Vice
President

			
	TPG BIOTECHNOLOGY PARTNERS III, L.P.	 		 	TPG ICEBERG CO-INVEST LLC
					
	By:	 	TPG Biotechnology GenPar III, L.P.,	 		 	By:	 	  

	its General Partner	 		 		 	Name: Ronald Cami
		 		 		 		 	Title:   Vice President
	By:	 	TPG Biotech Advisors III, LLC,	 		 		 	
	its General Partner	 		 		 	
					
	By:	 	  
	 		 		 	
		 	 Name: Ronald Cami
 Title:   Vice
President
	 		 		 	
				
	TPG FOF VI SPV, L.P.	 		 		 	
					
	By:	 	TPG Advisors VI, Inc., its General Partner	 		 		 	
					
	By:	 	  
	 		 		 	
		 	 Name: Ronald Cami
 Title:   Vice
President
	 		 		 	

  
 [Signature Page to
Stockholders Agreement] 

 
			
	CPP INVESTMENT BOARD PRIVATE HOLDINGS INC.
		
	By:	 	  

		 	Name:
		 	Title:   Authorized Signatory
		
	By:	 	  

		 	Name:
		 	Title:   Authorized Signatory

  
 [Signature Page to
Stockholders Agreement] 

 
			
	GREEN EQUITY INVESTORS V, L.P.
		
	By:	 	GEI CAPITAL V, LLC, its General Partner
		
	By:	 	  

		 	Name:
		 	Title:
	
	GREEN EQUITY INVESTORS SIDE V, L.P.
		
	By:	 	GEI CAPITAL V, LLC, its General Partner
		
	By:	 	  

		 	Name:
		 	Title:
	
	LGP ICEBERG COINVEST, LLC
		
	By:	 	
		
	By:	 	  

		 	Name:
		 	Title:

  
 [Signature Page to
Stockholders Agreement] 

 Exhibit 1 

Form of Indemnification Agreement 

[Attached as Exhibit 10.27]EX-10.3

 Exhibit 10.3 

EXECUTION COPY 
 MANAGEMENT
SERVICES AGREEMENT 
 This Management Services Agreement (the “Agreement”) is entered into as of February 26, 2010
by and among Healthcare Technology Acquisition, Inc., a Delaware corporation (“Merger Sub”), Healthcare Technology Intermediate, Inc. (“Intermediate”), Healthcare Technology Intermediate Holdings, Inc. (together
with Intermediate, “Intermediate Holdings”), Healthcare Technology Holdings, Inc., a Delaware corporation (“Parent”, and together with Merger Sub and Intermediate Holdings, the “Companies”), TPG
Capital, L.P. (“TPG”), TPG Growth, LLC (“TPG Growth”), CPP Investment Board Private Holdings Inc. (“CPPIB”) and Leonard Green & Partners, L.P. (“LGP” and, together with
TPG, TPG Growth and CPPIB, the “Managers”). 
 WHEREAS, Parent, Merger Sub and IMS Health Incorporated, a Delaware
corporation (“IMS”), entered into an Agreement and Plan of Merger, dated as of November 5, 2009 (as amended from time to time, the “Merger Agreement”); 

WHEREAS, in accordance with the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into
IMS, with IMS as the surviving corporation (the “Merger”); 
 WHEREAS, the Companies wish to retain the Managers to provide
certain management, advisory and consulting services to the Companies, and the Managers are willing to provide such services on the terms set forth below. 

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto, intending to be legally bound, hereby agree as
follows: 
 1. Services. Each Manager hereby severally agrees that, during the term of this Agreement (the “Term”),
it will provide to the Companies, to the extent requested by the Companies and mutually agreed by the Companies and such Manager, by and through itself and/or such Manager’s successors, assigns, affiliates, officers, employees and/or
representatives and third parties (collectively hereinafter referred to as the “Manager Designees”), as such Manager in its sole discretion may designate from time to time, management, advisory and consulting services in relation to
the affairs of the Companies. Such management, advisory and consulting services shall include, without limitation: 
 (a) advice in
connection with the negotiation and consummation of agreements, contracts, documents and instruments necessary to provide the Companies with financing on terms and conditions satisfactory to the Companies; 

(b) advice in connection with acquisition, disposition and change of control transactions involving any of the Companies or any of their
direct or indirect subsidiaries or any of their respective successors; 
 (c) financial, managerial and operational advice in connection
with day-to-day operations, including, without limitation, advice with respect to the development and implementation of strategies for improving the operating, marketing and financial performance of the Companies and/or their respective
subsidiaries; and 

 (d) such other services (which may include financial and strategic planning and analysis,
consulting services, human resources and executive recruitment services and other services) as such Manager and the Companies may from time to time agree in writing. 

Each of the Managers or their respective Manager Designees will devote such time and efforts to the performance of the services contemplated
hereby as such Manager deems reasonably necessary or appropriate; provided, however, that no minimum number of hours is required to be devoted by any Manager or Manager Designee on a weekly, monthly, annual or other basis. The
Companies acknowledge that each of the Manager’s or Manager Designee’s services are not exclusive to the Companies or their respective subsidiaries and that each Manager and Manager Designee may render similar services to other persons and
entities. The Managers and the Companies understand that the Companies or their respective subsidiaries may at times engage one or more investment bankers or financial advisers to provide services in addition to, but not in lieu of, services
provided by the Managers and the Manager Designees under this Agreement; provided that any such engagement will be made pursuant to the terms of the Shareholders’ Agreement, dated as of February 26, 2010, among the Companies,
affiliates of the Managers and certain other parties (as may be amended from time to time, the “Shareholders’ Agreement”). In providing services to the Companies or their respective subsidiaries, the Managers and Manager
Designees will act as independent contractors, and it is expressly understood and agreed that this Agreement is not intended to create, and does not create, any partnership, agency, joint venture or similar relationship and that no party has the
right or ability to contract for or on behalf of any other party or to effect any transaction for the account of any other party. 
 2.
Payment of Fees. 
 (a) On the date hereof, the Companies, jointly and severally, will pay to the Managers (or their respective
Manager Designees) an aggregate transaction fee (the “Transaction Fee”) equal to $60,000,000.00. The Transaction Fee will be divided among the Managers as follows: (i) TPG will be entitled to 62.85%; (ii) TPG Growth will
be entitled to 0.54%; (iii) LGP will be entitled to 6.27%; and (iv) CPPIB will be entitled to 30.34%. In addition to the Transaction Fee, on the date hereof, the Companies will pay to the Managers (or their respective Manager Designees),
an amount equal to all out-of pocket expenses incurred by or on behalf of each Manager or their respective affiliates, including, without limitation, (i) the reasonable fees, expenses and disbursements of lawyers, accountants, consultants and
other advisors that may have been retained by such Manager or its respective affiliates and (ii) any fees (including any financing fees) related to the Merger incurred by such Manager or its respective affiliates (all such fees and expenses, in
the aggregate, the “Covered Costs”). 
 (b) During the Term, the Companies, jointly and severally, will pay to the Managers
(or their respective Manager Designees) an aggregate annual Monitoring Fee (the “Monitoring Fee”) equal to $7,500,000.00 as compensation for the services provided by the Managers or the Manager Designees under this Agreement, such
fee being payable by the Companies quarterly in advance; provided that the Monitoring Fee payable in respect of the period from the date hereof through the end of the first calendar quarter of 2010 shall be payable on the date hereof and
shall be pro-rated based on the number of days in such period. 

  
 2 

 (c) During the Term, the Managers (or their respective Manager Designees) will advise the
Companies in connection with the consummation of any financing or refinancing (equity or debt), dividend, recapitalization, acquisition, disposition and spin-off or split-off transactions involving the Companies or any of their direct or indirect
subsidiaries (however structured), and the Companies will pay to the Managers (or their respective Manager Designees) an aggregate fee (the “Subsequent Fee”) in connection with each such transaction equal to customary fees charged
by internationally-recognized investment banks for serving as a financial advisor in similar transactions, such fee to be due and payable for the foregoing services at the closing of such transaction. 

(d) Each payment made pursuant to this Section 2 will be paid by wire transfer of immediately available funds to the accounts specified
on Schedule 1 hereto, or to such other account(s) as the respective Managers may specify to the Companies in writing prior to such payment. Each payment made pursuant to this Section 2 (other than the Transaction Fee and Covered Costs)
shall be allocated among the Managers (or their respective Manager Designees) as follows: (i) TPG will be entitled to 57.60%; (ii) TPG Growth will be entitled to 1.07%; (iii) CPPIB will be entitled to 28.80%; and (iv) LGP will be
entitled to 12.53%; provided that such allocation shall be adjusted proportionately to reflect any transfers of Company Shares (as defined in the Shareholders’ Agreement) of Parent owned by investment funds affiliated with a Manager
and/or entities controlled by affiliates of such Manager following the date hereof (such Manager, a “Transferring Manager”), other than (x) transfers to affiliates of such Transferring Manager permitted pursuant to
Section 4.2 of the Shareholders’ Agreement or (y) pro rata transfers by the investment funds affiliated with each of the Managers and the entities controlled by affiliates of such Managers (such allocation, as adjusted from time to
time, the “Relative Interests”); and provided, further, that any Company Shares transferred by TPG Iceberg Co-Invest LLC shall be allocated between TPG and CPPIB pro rata in accordance with their
respective Proportionate Shares (as defined in the Shareholders’ Agreement). 
 (e) The Companies shall be entitled to deduct and
withhold from the amounts otherwise payable hereunder such amounts as are required to be deducted and withheld under applicable law. Any amounts so withheld or deducted shall be treated for the purposes of this Agreement as paid to the Manager in
respect of which such withholding or deduction was made. 
 3. Deferral. Any fee (or portion thereof) that would have been payable to
the Managers (or their respective Manager Designees) pursuant to Section 2 above absent the restrictions, if any, in any financing or similar agreements (the “Financing Documents”) applicable to the Companies (the
“Deferred Fees”) will accrue upon the immediately succeeding period in which such amounts could, consistent with the Financing Documents, be paid, and will be paid in such succeeding period (in addition to such other amounts that
would otherwise be payable at such time) in the manner set forth in Section 2. 
 4. Term. This Agreement will continue in full
force and effect until December 31, 2020; provided that this Agreement shall be automatically extended each December 31 for an 

  
 3 

 
additional year unless TPG provides written notice of its desire not to automatically extend the term of this Agreement to the other parties hereto at least ninety (90) days prior to such
December 31; provided, further, that this Agreement (x) may be terminated at any time by TPG, (y) shall terminate automatically immediately prior to the earlier of (i) the consummation by any of the Companies, one
or more of their subsidiaries or any of their successors of an IPO (an “IPO”), as such term is defined in the Shareholders’ Agreement, or (ii) a transfer or issuance of equity securities of any of the Companies (including
by way of a merger, consolidation, amalgamation, share exchange or other form of similar business combination), in a single or series of related transactions, resulting in a person or persons other than the existing stockholders owning, directly or
indirectly, a majority of the voting power of the applicable Company, upon the consummation of such transfer or issuance, or the sale of all or substantially all of the assets of any of the Companies (any such sale transaction, a
“Sale”), in each case, unless otherwise agreed by TPG and (z) shall immediately terminate with respect to any Manager upon the disposition of all Company Shares held by such Manager and such Manager’s affiliates. For the
avoidance of doubt, termination of this Agreement will not relieve a party from liability for any breach of this Agreement on or prior to such termination. In the event of a termination of this Agreement, the Companies will pay the Managers (or
their respective Manager Designees) (i) all unpaid Transaction Fees (pursuant to Section 2(a) above), Covered Costs (pursuant to Section 2(a) above), Monitoring Fees (pursuant to Section 2(b) above), Subsequent Fees (pursuant to
Section 2(c) above), Deferred Fees (pursuant to Section 3 above) and Reimbursable Expenses (pursuant to Section 5(a) below) due with respect to periods prior to the date of termination plus (ii) the sum of the net present values
(using discount rates equal to the then yield on U.S. Treasury Securities of like maturity) of the Monitoring Fees that would have been payable with respect to the period from the date of termination until the expiration date in effect immediately
prior to such termination. The amounts described in clause (ii) above shall be divided among the Managers in accordance with the Managers’ Relative Interests, as of such date of termination. In the event of an IPO or Sale that, in either
case, includes non-cash consideration, each Manager may elect for it or its Manager Designees to receive all or any portion of any amounts payable pursuant to this Agreement as a result of such IPO or Sale in the form of such non-cash consideration,
valued at the sale price. All of Section 4 through Section 14 will survive termination of this Agreement with respect to matters arising before or after such termination. 

5. Expenses; Indemnification. 

(a) Expenses. The Companies, jointly and severally, will pay to the Managers (or their respective Manager Designees) on demand all
Reimbursable Expenses whether incurred prior to or following the date of this Agreement. As used herein, “Reimbursable Expenses” means (i) all out-of-pocket expenses incurred from and after the consummation of the Merger
relating to the services provided by the Managers or their respective Manager Designees to the Companies or any of their affiliates from time to time (including, without limitation, all travel related expenses), (ii) all out-of-pocket legal
expenses incurred by any Managers, their respective affiliates or their respective Manager Designees in connection with the enforcement of rights or taking of actions under this Agreement, the Merger Agreement or any related documents or
instruments, and (iii) all expenses incurred by the Managers, their respective affiliates or their respective Manager Designees on behalf of the Companies, including in connection with their management and operations, whether incurred prior to
or following the date of this Agreement. 

  
 4 

 (b) Indemnity and Liability. The Companies, jointly and severally, will indemnify,
exonerate and hold the Managers, the Manager Designees and each of their respective partners, shareholders, members, affiliates, associated investment funds, directors, officers, fiduciaries, managers, controlling persons, employees and agents and
each of the partners, shareholders, members, affiliates, associated investment funds, directors, officers, fiduciaries, managers, controlling persons, employees and agents of each of the foregoing (collectively, the “Indemnitees”)
free and harmless from and against any and all actions, causes of action, suits, claims, liabilities, losses, damages and costs and out-of-pocket expenses in connection therewith (including attorneys’ fees and expenses) incurred by the
Indemnitees or any of them before or after the date of this Agreement (collectively, the “Indemnified Liabilities”), arising out of any action, cause of action, suit, arbitration, investigation or claim (whether between the relevant
Indemnitee and any of the Companies or involving a third party claim against the relevant Indemnitee) arising out of, or in any way relating to (i) this Agreement, the Merger Agreement, any transaction to which any of the Companies is a party
or any other circumstances with respect to any of the Companies or (ii) operations of, or services provided by any of the Managers or the Manager Designees to, the Companies, or any of their respective affiliates from time to time;
provided that the foregoing indemnification rights will not be available to the extent that any such Indemnified Liabilities arose on account of such Indemnitee’s gross negligence or willful misconduct; and provided,
further, that if and to the extent that the foregoing undertaking may be unavailable or unenforceable for any reason, the Companies hereby agree to make the maximum contribution to the payment and satisfaction of each of the Indemnified
Liabilities which is permissible under applicable law. For purposes of this Section 5(b), none of the circumstances described in the limitations contained in the two provisos in the immediately preceding sentence will be deemed to apply absent
a final non-appealable judgment of a court of competent jurisdiction to such effect, in which case to the extent any such limitation is so determined to apply to any Indemnitee as to any previously advanced indemnity payments made by the Companies,
then such payments will be promptly repaid by such Indemnitee to the Companies without interest. The rights of any Indemnitee to indemnification hereunder will be in addition to any other rights any such person may have under any other agreement or
instrument referenced above or any other agreement or instrument to which such Indemnitee is or becomes a party or is or otherwise becomes a beneficiary or under law or regulation; provided that (i) the Companies hereby agree that they
are the indemnitors of first resort under this Agreement and under any other applicable indemnification agreement (i.e., their obligations to Indemnitees under this Agreement or any other agreement or undertaking to provide advancement and/or
indemnification to such Indemnitees are primary and any obligation of any Manager (or any affiliate thereof other than a Company) to provide advancement or indemnification for the Indemnified Liabilities incurred by Indemnitees are secondary), and
(ii) if any Manager (or any affiliate thereof) pays or causes to be paid, for any reason, any amounts otherwise indemnifiable hereunder or under any other indemnification agreement (whether pursuant to contract, by-laws or charter) with any
Indemnitee, then (x) such Manager (or such affiliate, as the case may be) shall be fully subrogated to all rights of such Indemnitee with respect to such payment and (y) the Companies shall fully indemnify, reimburse and hold harmless such
Manager (or such other affiliate) for all such payments actually made by such Manager (or such other affiliate) and irrevocably waive, relinquish and release the Managers for contribution, subrogation or any other recovery of any kind in respect of
any advancement of expenses or indemnification hereunder. 

  
 5 

 6. Disclaimer and Limitation of Liability; Opportunities. 

(a) Disclaimer; Standard of Care. None of the Managers nor any of their respective Manager Designees makes any representations or
warranties, express or implied, in respect of the services to be provided by the Managers or the Manager Designees hereunder. In no event will any Manager, its Manager Designees or related Indemnitees be liable to the Companies or any of their
respective affiliates for any act, alleged act, omission or alleged omission that does not constitute gross negligence or willful misconduct of such Manager or its Manager Designees as determined by a final, non-appealable determination of a court
of competent jurisdiction. 
 (b) Freedom to Pursue Opportunities. In recognition that the Managers, the Manager Designees and their
respective Indemnitees currently have, and will in the future have or will consider acquiring, investments in numerous companies with respect to which the Managers, the Manager Designees or their respective Indemnitees may serve as an advisor, a
director or in some other capacity, and in recognition that each Manager, each Manager Designee and their respective Indemnitees have myriad duties to various investors and partners, and in anticipation that the Companies, on the one hand and each
Manager and Manager Designee (or one or more of its respective Indemnitees or portfolio companies), on the other hand, may engage in the same or similar activities or lines of business and have an interest in the same areas of corporate
opportunities, and in recognition of the benefits to be derived by the Companies hereunder and in recognition of the difficulties which may confront any advisor who desires and endeavors fully to satisfy such advisor’s duties in determining the
full scope of such duties in any particular situation, the provisions of this Section 6(b) are set forth to regulate, define and guide the conduct of certain affairs of the Companies as they may involve the Managers, the Manager Designees or
their respective Indemnitees. Except as a Manager or Manager Designee may otherwise agree in writing after the date hereof: 

(i) Such Manager or Manager Designee and their respective Indemnitees will have the right: (A) to directly or indirectly
engage in any business (including, without limitation, any business activities or lines of business that are the same as or similar to those pursued by, or competitive with, the Companies and their subsidiaries), (B) to directly or indirectly
do business with any client or customer of the Companies and their subsidiaries, (C) to take any other action that such Manager or Manager Designee believes in good faith is necessary to or appropriate to fulfill its obligations as described in
the first sentence of this Section 6(b) to third parties, (D) not to communicate or present potential transactions, matters or business opportunities to the Companies or any of their subsidiaries, and to pursue, directly or indirectly, any
such opportunity for itself, and to direct any such opportunity to another person and (E) to take any other action permitted pursuant to Section 7.4 of the Shareholders’ Agreement or Article 11 of the amended and restated certificate
of incorporation of Parent. 

  
 6 

 (ii) Such Manager, Manager Designee and their respective Indemnitees will have no
duty (contractual or otherwise) to communicate or present any corporate opportunities to the Companies or any of their affiliates or to refrain from any actions specified in Section 6(b)(i), and the Companies, on their own behalf and on behalf
of their affiliates, hereby renounce and waive any right to require such Manager, Manager Designee or any of their respective Indemnitees to act in a manner inconsistent with the provisions of this Section 6(b). 

(iii) Except as provided in this Section 6(a), none of the Managers, the Manager Designees nor any of their respective
Indemnitees will be liable to the Companies or any of their affiliates for breach of any duty (contractual or otherwise) by reason of any activities or omissions of the types referred to in this Section 6(b) or of any such person’s
participation therein. 
 (c) Limitation of Liability. In no event will any Manager, its Manager Designees or any of its related
Indemnitees be liable to the Companies or any of their affiliates for any indirect, special, incidental or consequential damages, including, without limitation, lost profits or savings, whether or not such damages are foreseeable, or for any third
party claims (whether based in contract, tort or otherwise), relating to, in connection with or arising out of this Agreement, before or after termination of this Agreement, including without limitation the services to be provided by the Managers or
the Manager Designees hereunder, or for any act or omission that does not constitute gross negligence or willful misconduct of such Manager or its Manager Designees or in excess of the fees received by the applicable Manager or Manager Designee
hereunder. 
 7. Assignment, etc. Except as provided below, and without limiting the Managers’ rights to have payments owing to
it under this Agreement to be paid to its Manager Designees or other affiliates, none of the parties hereto will have the right to assign this Agreement without the prior written consent of each of the other parties. Notwithstanding the foregoing,
(a) any Manager may assign all or part of its rights and obligations hereunder to any of its respective affiliates which provides services similar to those called for by this Agreement, in which event such Manager will relinquish its rights to
fees under Section 2 and reimbursement of expenses under Section 2(a) and Section 5(a) and be released from all of its obligations hereunder (other than any liabilities not limited by Section 6(c)) and (b) the provisions
hereof for the benefit of Indemnitees of the Managers will inure to the benefit of such Indemnitees and their successors and assigns. 
 8.
Amendments and Waivers. No amendment or waiver of any term, provision or condition of this Agreement will be effective without the express written consent of the Companies and TPG; provided that any such amendment or waiver that would
be disproportionately adverse to any Manager relative to the other Managers shall require the prior written consent of such Manager; and provided, further, that any Manager may waive any portion of any fee to which it is entitled
pursuant to this Agreement, and, unless otherwise directed by such Manager, such waived portion will revert to the Companies. No waiver on any one occasion will extend to or effect or be construed as a waiver of any right or remedy on any

  
 7 

 
future occasion. No course of dealing of any person nor any delay or omission in exercising any right or remedy will constitute an amendment of this Agreement or a waiver of any right or remedy
of any party hereto. 
 9. Governing Law; Jurisdiction. THIS AGREEMENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF
THE STATE OF NEW YORK, WITHOUT REGARD TO THE CONFLICTS OF LAW PRINCIPLES THEREOF. ANY ACTION OR PROCEEDING AGAINST THE PARTIES RELATING IN ANY WAY TO THIS AGREEMENT MAY BE BROUGHT AND ENFORCED EXCLUSIVELY IN THE COURTS OF THE STATE OF NEW YORK OR
(TO THE EXTENT SUBJECT MATTER JURISDICTION EXISTS THEREFOR) THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK SITTING IN MANHATTAN, AND THE PARTIES IRREVOCABLY SUBMIT TO THE JURISDICTION OF BOTH SUCH COURTS IN RESPECT OF ANY
SUCH ACTION OR PROCEEDING. 
 10. Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY. 

11. Entire Agreement. This Agreement contains the entire understanding of the parties with respect to the subject matter hereof and
supersedes any prior communication or agreement with respect thereto. 
 12. Notice. All notices, demands, and communications
required or permitted under this Agreement will be in writing and will be effective if served upon such other party and such other party’s copied persons as specified below to the address set forth for it below (or to such other address as such
party will have specified by notice to each other party) if (i) delivered personally, (ii) sent and received by facsimile, (iii) sent by electronic mail or (iv) sent by certified or registered mail or by Federal Express, UPS or
any other comparably reputable overnight courier service, postage prepaid, to the appropriate address as follows: 
  

			
	If to the Companies (with a copy, which will not constitute notice, to each Manager), to:
	
	c/o IMS Health Incorporated
	901 Main Avenue
	Norwalk, Connecticut 06851
	Attention: General Counsel
	Facsimile: (203) 845-5302
	Email: Hashman@imshealth.com
	
	with a copy (which will not constitute notice) to:
	
	Ropes & Gray LLP
	One International Place

  
 8 

			
	Boston, Massachusetts 02110
	Attention:	  	Alfred O. Rose
		  	Amanda McGrady Morrison
	Facsimile: (617) 951-7050
	Email:  alfred.rose@ropesgray.com
	            amanda.morrison@ropesgray.com
	
	If to TPG, to:
	
	TPG Capital, L.P.
	301 Commerce Street, Suite 3300
	Fort Worth, Texas 76102
	Attention:  General Counsel
	Telephone:  (817) 871-4000
	Facsimile:  (817) 871-4088
	Email: cbode@tpg.com
	
	with a copy (which will not constitute notice) to:
	
	Cleary Gottlieb Steen & Hamilton LLP
	One Liberty Plaza
	New York, NY 10006
	Attention:	  	Michael A. Gerstenzang
		  	Elizabeth Lenas
	Telephone:  (212) 225-2000
	Facsimile: (212) 225-3999
	Email:  mgerstenzang@cgsh.com
	             elenas@cgsh.com
	
	If to TPG Growth, to:
	
	TPG Growth, LLC
	301 Commerce Street, Suite 3300
	Fort Worth, Texas 76102
	Attention:  General Counsel
	Telephone:  (817) 871-4000
	Facsimile:  (817) 871-4088
	Email:  cbode@tpg.com
	
	with a copy (which will not constitute notice) to:
	
	Cleary Gottlieb Steen & Hamilton LLP
	One Liberty Plaza
	New York, NY 10006
	Attention:	  	Michael A. Gerstenzang
		  	Elizabeth Lenas

  
 9 

			
	Telephone: (212) 225-2000
	Facsimile:(212) 225-3999
	Email:	  	mgerstenzang@cgsh.com
	            elenas@cgsh.com
	
	If to CPPIB, to:
	
	CPP Investment Board Private Holdings Inc.
	One Queen Street East
	Suite 2700, P.O. Box 101
	Toronto Ontario M5C 2W5
	Attention: Andre Bourbonnais
	Telephone: (416) 868-5003
	Facsimile: (416) 868-8684
	Email: abourbonnais@cppib.ca
	
	with a copy (which will not constitute notice) to:
	
	Torys LLP
	237 Park Avenue
	New York, NY 10017
	Attention: Darren Baccus
	Telephone: (212) 880-6116
	Facsimile: (212) 682-0200
	
	If to LGP to:
	
	Leonard Green & Partners, L.P.
	11111 Santa Monica Boulevard Suite 2000
	Los Angeles, CA 90025
	Attention: John Baumer
	Telephone:  (310) 954-0416
	Facsimile: (310) 954-0404
	E-mail: baumer@leonardgreen.com
	
	with a copy (which will not constitute notice) to:
	
	Latham & Watkins LLP
	885 Third Avenue
	New York, NY 10022
	Attention: Howard Sobel
	Telephone:  (212) 906-1200
	Facsimile:  (212) 751-4864
	E-mail:  howard.sobel@lw.com

  
 10 

 Unless otherwise specified herein, such notices or other communications will be deemed effective,
(a) on the date received, if personally delivered or sent by facsimile or electronic mail during normal business hours, (b) on the business day after being received if sent by facsimile or electronic mail other than during normal business
hours, (c) one business day after being sent by Federal Express, DHL or UPS or other comparably reputable delivery service and (d) five business days after being sent by registered or certified mail. Each of the parties hereto will be
entitled to specify a different address by giving notice as aforesaid to each of the other parties hereto. 
 13. Severability. If in
any proceedings a court will refuse to enforce any provision of this Agreement, then such unenforceable provision will be deemed eliminated from this Agreement for the purpose of such proceedings to the extent necessary to permit the remaining
provisions to be enforced. To the full extent, however, that the provisions of any applicable law may be waived, they are hereby waived to the end that this Agreement be deemed to be valid and binding agreement enforceable in accordance with its
terms, and in the event that any provision hereof will be found to be invalid or unenforceable, such provision will be construed by limiting it so as to be valid and enforceable to the maximum extent consistent with and possible under applicable
law. 
 14. Counterparts. This Agreement may be executed in any number of counterparts and by each of the parties hereto in separate
counterparts, each of which when so executed will be deemed to be an original and all of which together will constitute one and the same agreement. 

  
 11 

 IN WITNESS WHEREOF, each of the parties has duly executed this Agreement as of the date first
above written. 
  

					
	Healthcare Technology Holdings, Inc.
		
	By:	 	 /s/ Clive D. Bode

		 	Name:	 	Clive D. Bode
		 	Title:	 	Vice President
	
	Healthcare Technology Intermediate, Inc.
		
	By:	 	 /s/ Clive D. Bode

		 	Name:	 	Clive D. Bode
		 	Title:	 	Vice President
	
	Healthcare Technology Intermediate Holdings, Inc.
		
	By:	 	 /s/ Clive D. Bode

		 	Name:	 	Clive D. Bode
		 	Title:	 	Vice President
	
	Healthcare Technology Acquisition, Inc.
		
	By:	 	 /s/ Clive D. Bode

		 	Name:	 	Clive D. Bode
		 	Title:	 	Vice President

  
 Management Services
Agreement 

 
									
	TPG Capital, L.P.
		
	By:	 	Tarrant Capital, LLC its General Partner
				
		 		 	By:	 	 /s/ Clive D. Bode

		 		 		 	Name:	 	Clive D. Bode
		 		 		 	Title:	 	Vice President
	
	TPG Growth, LLC
				
		 		 	By:	 	 /s/ Clive D. Bode

		 		 		 	Name:	 	Clive D. Bode
		 		 		 	Title:	 	Vice President

  
 Management Services
Agreement 

 
					
	CPP Investment Board Private Holdings Inc.
		
	  By:	 	 /s/ André Bourbonnais

		 	Name:	 	André Bourbonnais
		 	Title:	 	Authorized Signatory
		
	  By:	 	 /s/ Mark Wiseman

		 	Name:	 	Mark Wiseman
		 	Title:	 	Authorized Signatory

  
 Management Services
Agreement 

 
					
	Leonard Green & Partners, L.P.
		
	    By:	 	 /s/ Leonard Green & Partners, L.P.

		 		 	
		 		 	

  
 Management Services
Agreement 

 Schedule 1 

Wire Transfer Instructions for TPG: [            ] 

Wire Transfer Instructions for TPG Growth: [            ] 

Wire Transfer Instructions for CPPIB: [            ] 

Wire Transfer Instructions for LGP: [            ] 

  
 Management Services
Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}]]